<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31299" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Malignant Salivary Gland Tumors</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Young</surname>
            <given-names>Allen</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Okuyemi</surname>
            <given-names>Oluwafunmilola T.</given-names>
          </name>
          <aff>University of Nevada Las Vegas School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Allen Young declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Oluwafunmilola Okuyemi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31299.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Salivary gland tumors are a rare group of complex, heterogeneous histologies located in the parotid gland, submandibular gland, sublingual gland, and minor salivary glands of the upper aerodigestive tract. This diverse group of malignant tumors has a wide range of etiology, pathophysiology, treatment, and prognosis. This activity reviews the evaluation and treatment of malignant salivary gland tumors and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of malignant salivary gland tumors and associated conditions.</p></list-item><list-item><p>Assess&#x000a0;the physical examination of patients with malignant salivary gland tumors.</p></list-item><list-item><p>Evaluate&#x000a0;the treatment options available for malignant salivary gland tumors.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31299&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31299">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31299.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Salivary gland tumors are a rare group of complex, heterogeneous histologies located in the parotid, submandibular, sublingual, and minor salivary glands of the upper aerodigestive tract. The wide variety of tumor etiology, microscopic histology, growth patterns, and tumor characteristics can make diagnosis and treatment challenging for clinicians. The World Health Organization in 2005 recognized 24 different malignant salivary gland cancers; the most common histologies include mucoepidermoid carcinoma (MEC), acinic cell carcinoma (ACC), adenoid cystic carcinoma (AdCC), carcinoma ex-pleomorphic adenoma (CExPA), and adenocarcinoma.<xref ref-type="bibr" rid="article-31299.r1">[1]</xref></p>
      </sec>
      <sec id="article-31299.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact etiology of salivary gland cancer is unknown. Still, various mechanisms have been proposed, including radiation, viruses (EBV and HIV), immunosuppression, ultraviolet light exposure, occupational exposures in rubber or nickel industries,&#x000a0;prior diagnosis of medulloblastoma,&#x000a0;prior diagnosis of basal cell carcinoma,&#x000a0;androgen receptor expression,&#x000a0;and genetics.<xref ref-type="bibr" rid="article-31299.r2">[2]</xref><xref ref-type="bibr" rid="article-31299.r3">[3]</xref><xref ref-type="bibr" rid="article-31299.r4">[4]</xref><xref ref-type="bibr" rid="article-31299.r5">[5]</xref><xref ref-type="bibr" rid="article-31299.r6">[6]</xref><xref ref-type="bibr" rid="article-31299.r7">[7]</xref><xref ref-type="bibr" rid="article-31299.r8">[8]</xref>&#x000a0;In studies involving Japanese survivors of the atomic bomb and patients who received radiation treatment during childhood for benign conditions, radiation exposure was identified as a significant risk factor for the development of salivary malignancies.<xref ref-type="bibr" rid="article-31299.r9">[9]</xref><xref ref-type="bibr" rid="article-31299.r10">[10]</xref>&#x000a0;MEC appears to be the most common salivary gland malignancy associated with radiation exposure.<xref ref-type="bibr" rid="article-31299.r11">[11]</xref><xref ref-type="bibr" rid="article-31299.r12">[12]</xref>&#x000a0;Compared to other head and neck cancers, the risk of developing malignant salivary gland tumors from exposure to tobacco and alcohol has been controversial, with several studies noting both positive association&#x000a0;and no appreciable association.&#x000a0;Sawabe et al found no significant association between cigarette smoking and&#x000a0;MEC but did show a positive correlation between tobacco smoking and other malignant salivary histologies.<xref ref-type="bibr" rid="article-31299.r13">[13]</xref><xref ref-type="bibr" rid="article-31299.r14">[14]</xref>&#x000a0;Chronic inflammation of the salivary glands has not been established as a risk factor. However, autoimmune conditions such as Sjogren syndrome may predispose an individual to develop a salivary gland malignancy such as lymphoma.<xref ref-type="bibr" rid="article-31299.r15">[15]</xref><xref ref-type="bibr" rid="article-31299.r16">[16]</xref><xref ref-type="bibr" rid="article-31299.r17">[17]</xref><xref ref-type="bibr" rid="article-31299.r18">[18]</xref>&#x000a0;Although squamous cell carcinoma (SCC) of the head and neck has been linked to tobacco, alcohol, and UV exposure, the presence of primary SCC in the salivary glands is rare and does not&#x000a0;retain&#x000a0;the same risk factors.<xref ref-type="bibr" rid="article-31299.r19">[19]</xref> The most significant risk factor for primary SCC of the salivary glands appears to be prior gland radiation.<xref ref-type="bibr" rid="article-31299.r20">[20]</xref><xref ref-type="bibr" rid="article-31299.r21">[21]</xref>&#x000a0;</p>
        <p>Most melanoma cases of the major salivary glands are attributed to metastasis from cutaneous sources of the upper face and scalp.<xref ref-type="bibr" rid="article-31299.r22">[22]</xref>&#x000a0;However, the presence of melanoma in the parotid without any other primary sites has been reported in the literature.<xref ref-type="bibr" rid="article-31299.r23">[23]</xref>&#x000a0;Although the exact etiology is unknown, melanocytes have been found&#x000a0;in the&#x000a0;intralobular duct of the parotid gland and have been postulated to serve as the cells of origin for primary melanoma of the salivary glands.<xref ref-type="bibr" rid="article-31299.r24">[24]</xref><xref ref-type="bibr" rid="article-31299.r25">[25]</xref>&#x000a0;The development of non-Hodgkin lymphoma (NHL) of the salivary glands has been associated with a prior diagnosis of the autoimmune disease, Sjogren syndrome (SS). Studies have shown that 4.3% of patients with Sjogren syndrome develop NHL within 5-10 years.<xref ref-type="bibr" rid="article-31299.r26">[26]</xref><xref ref-type="bibr" rid="article-31299.r27">[27]</xref></p>
      </sec>
      <sec id="article-31299.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Salivary gland malignancies comprise 0.5 to 1.2% of all cancers and 5% of head and neck cancers.<xref ref-type="bibr" rid="article-31299.r28">[28]</xref><xref ref-type="bibr" rid="article-31299.r29">[29]</xref><xref ref-type="bibr" rid="article-31299.r30">[30]</xref>&#x000a0;They more commonly affect women with a male-to-female ratio of 1&#x000a0;to 1.5.<xref ref-type="bibr" rid="article-31299.r31">[31]</xref>&#x000a0;Malignant lesions are found in about 21.7% of all salivary gland neoplasms.<xref ref-type="bibr" rid="article-31299.r32">[32]</xref><xref ref-type="bibr" rid="article-31299.r33">[33]</xref>&#x000a0;Most malignant cases occur in the parotid, followed by the submandibular, sublingual, and minor salivary glands.<xref ref-type="bibr" rid="article-31299.r34">[34]</xref>&#x000a0;The probability of malignancy in a parotid mass ranges from 15% to 32%, compared to 41% to 50% in a submandibular mass, 70% to 90% in minor salivary gland masses, and almost 100% in sublingual masses.<xref ref-type="bibr" rid="article-31299.r35">[35]</xref>&#x000a0;Salivary gland tumors in children are more likely to be malignant. Malignant tumors in children under 10 years old tend to be of a higher grade with poorer prognosis.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref> Salivary tumors in children older than 10 were benign in 85% of cases, similar to that of the adult population.<xref ref-type="bibr" rid="article-31299.r37">[37]</xref>&#x000a0;The most common pediatric malignant salivary gland tumors include MEC, adenocarcinoma, and ACC.<xref ref-type="bibr" rid="article-31299.r28">[28]</xref><xref ref-type="bibr" rid="article-31299.r30">[30]</xref></p>
        <p>The parotid gland harbors 60&#x000a0;to 75% of all salivary gland tumors.<xref ref-type="bibr" rid="article-31299.r38">[38]</xref>&#x000a0;The most common malignant tumors are MEC, AdCC, CExPA, adenocarcinoma, and SCC.<xref ref-type="bibr" rid="article-31299.r39">[39]</xref><xref ref-type="bibr" rid="article-31299.r40">[40]</xref>&#x000a0;The submandibular gland harbors 10-15% of all salivary gland tumors with an equal distribution of benign and malignant neoplasms.<xref ref-type="bibr" rid="article-31299.r41">[41]</xref>&#x000a0;AdCC is the most common malignant neoplasm in the submandibular gland, followed by MEC and CExPA. Less common tumors include ACC, salivary duct carcinoma, epi-myoepithelial carcinoma, carcinosarcoma, oncocytic carcinoma, and SCC.<xref ref-type="bibr" rid="article-31299.r41">[41]</xref> Malignant submandibular tumors are more common in the 6th decade with a predilection for men.<xref ref-type="bibr" rid="article-31299.r42">[42]</xref>&#x000a0;In the minor salivary glands, as many as 50% of tumors are malignant, most often located in the palate.<xref ref-type="bibr" rid="article-31299.r38">[38]</xref></p>
        <p>
<italic toggle="yes">Epidemiology of Specific Salivary Gland Malignancies</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>MEC is the most common salivary gland malignancy in adults and children.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref>&#x000a0;About 89% of cases are found in the parotid, followed by 8.4% in the submandibular gland and 0.4% in the sublingual gland.<xref ref-type="bibr" rid="article-31299.r43">[43]</xref>&#x000a0;There is an equal distribution between the sexes with a predilection for the 4th to 5th decade.<xref ref-type="bibr" rid="article-31299.r44">[44]</xref></p>
          </list-item>
          <list-item>
            <p>AdCC accounts for about 10% of all salivary gland neoplasms and 30% of all minor salivary gland tumors. It has a predilection for&#x000a0;patients in the 5th to 6th decade&#x000a0;with no difference in gender, although it tends to be more common in the submandibular gland in women.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref><xref ref-type="bibr" rid="article-31299.r45">[45]</xref><xref ref-type="bibr" rid="article-31299.r46">[46]</xref></p>
          </list-item>
          <list-item>
            <p>ACC is located in the parotid gland in more than 80% of all cases, submandibular glands in 4%, and intraoral minor salivary glands in 17%. Bilateral parotid involvement is seen in 3-5% of cases.<xref ref-type="bibr" rid="article-31299.r47">[47]</xref>&#x000a0;It has a predilection for women and more commonly occurs in the 5th decade.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref><xref ref-type="bibr" rid="article-31299.r44">[44]</xref><xref ref-type="bibr" rid="article-31299.r46">[46]</xref></p>
          </list-item>
          <list-item>
            <p>CExPA accounts for 5% to 15% of all salivary gland malignancies and can arise in up to 25% of untreated pleomorphic adenomas.<xref ref-type="bibr" rid="article-31299.r48">[48]</xref>&#x000a0;Malignant transformation is often seen in recurrent pleomorphic adenoma (PA), with the risk of transformation ranging from 5% to 10% for untreated pleomorphic adenomas over 15 years.<xref ref-type="bibr" rid="article-31299.r41">[41]</xref>&#x000a0;About 82% of cases occur in the parotid and submandibular glands, followed by 18% in the intraoral minor salivary glands.<xref ref-type="bibr" rid="article-31299.r41">[41]</xref></p>
          </list-item>
          <list-item>
            <p>Polymorphous Low-Grade Adenocarcinoma (PLGA) occurs almost exclusively in the minor salivary glands, with rare reports of it in the major salivary glands.<xref ref-type="bibr" rid="article-31299.r49">[49]</xref>&#x000a0;It is the second most common intraoral minor salivary gland malignancy after MEC.<xref ref-type="bibr" rid="article-31299.r49">[49]</xref><xref ref-type="bibr" rid="article-31299.r50">[50]</xref></p>
          </list-item>
          <list-item>
            <p>Salivary Duct Carcinoma accounts for 7&#x000a0;to 10% of all salivary gland tumors and is often found in the parotid in older men in the 6th to 7th decades.<xref ref-type="bibr" rid="article-31299.r30">[30]</xref><xref ref-type="bibr" rid="article-31299.r36">[36]</xref><xref ref-type="bibr" rid="article-31299.r51">[51]</xref>&#x000a0;It is a very aggressive malignancy of the salivary glands.</p>
          </list-item>
          <list-item>
            <p>SCC has a predilection for men and is usually found in the parotid. They are considered rare due to the infrequent occurrence of squamous metaplasia of ductal epithelium, which is thought to be responsible for the malignant transformation.<xref ref-type="bibr" rid="article-31299.r52">[52]</xref>&#x000a0;The specific etiology of the malignant transformation is not known, although there is evidence implicating high-risk HPV viruses.<xref ref-type="bibr" rid="article-31299.r53">[53]</xref>&#x000a0;High-grade MEC and extension from an extra-parotid source are often misdiagnosed as primary SCC of the parotid. The true incidence of primary squamous cell carcinoma of the parotid is unknown due to its rarity and its frequency of being a misclassification of metastatic SCC. Evidence from the literature suggests the true incidence may be around 0.75-1%.<xref ref-type="bibr" rid="article-31299.r54">[54]</xref>&#x000a0;Although a range of 0.3% to 4.3% has also been cited,&#x000a0;these higher frequencies are thought to be due to misrepresentations or misclassification of these tumors.<xref ref-type="bibr" rid="article-31299.r52">[52]</xref><xref ref-type="bibr" rid="article-31299.r55">[55]</xref><xref ref-type="bibr" rid="article-31299.r52">[52]</xref></p>
          </list-item>
          <list-item>
            <p>Primary melanoma of the salivary gland is extremely rare and accounts for 0.68% of malignant parotid neoplasms.<xref ref-type="bibr" rid="article-31299.r56">[56]</xref>&#x000a0;There is a predilection for males in the 6th to 7th decade.<xref ref-type="bibr" rid="article-31299.r19">[19]</xref><xref ref-type="bibr" rid="article-31299.r57">[57]</xref><xref ref-type="bibr" rid="article-31299.r58">[58]</xref> Most melanoma in the parotid is due to cutaneous and mucosal metastasis from the head and neck.<xref ref-type="bibr" rid="article-31299.r59">[59]</xref><xref ref-type="bibr" rid="article-31299.r60">[60]</xref></p>
          </list-item>
          <list-item>
            <p>NHL of the salivary gland accounts for less than 10% of malignant salivary gland tumors.<xref ref-type="bibr" rid="article-31299.r61">[61]</xref><xref ref-type="bibr" rid="article-31299.r62">[62]</xref><xref ref-type="bibr" rid="article-31299.r63">[63]</xref>&#x000a0;Although it encompasses less than 5% of all extranodal NHL, it is the most common extranodal lymphoma&#x000a0;at the neck, comprising two-thirds of all cases.<xref ref-type="bibr" rid="article-31299.r64">[64]</xref> It preferentially occurs in women and patients over 50 years old.<xref ref-type="bibr" rid="article-31299.r65">[65]</xref>&#x000a0;The most common variant of lymphoma associated with Sjogren Syndrome is mucosa-associated lymphoid tissue lymphoma (MALT), with 48% to 75% of all cases followed by diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma.<xref ref-type="bibr" rid="article-31299.r27">[27]</xref><xref ref-type="bibr" rid="article-31299.r61">[61]</xref><xref ref-type="bibr" rid="article-31299.r66">[66]</xref>&#x000a0;The majority of cases&#x000a0;occur in the parotid gland.<xref ref-type="bibr" rid="article-31299.r26">[26]</xref><xref ref-type="bibr" rid="article-31299.r67">[67]</xref><xref ref-type="bibr" rid="article-31299.r68">[68]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31299.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>MEC&#x000a0;arises from the epithelium of the interlobular and intralobular salivary ducts. The most common genetic finding is the chromosomal translocation t(11;19)(q21:p13), leading to the fusion of <italic toggle="yes">MECT1</italic> and <italic toggle="yes">MAML2</italic> genes, which is responsible for disrupting the <italic toggle="yes">NOTCH</italic> signaling pathway.<xref ref-type="bibr" rid="article-31299.r69">[69]</xref><xref ref-type="bibr" rid="article-31299.r70">[70]</xref>&#x000a0;This translocation is found in 50% to 70% of patients with MEC and is more often seen in low-grade tumors associated with a better prognosis.<xref ref-type="bibr" rid="article-31299.r71">[71]</xref><xref ref-type="bibr" rid="article-31299.r72">[72]</xref>&#x000a0;Over 50% of AdCC tumors contain the t(6;9)(q22-23;p23-24) translocation, which fuses the <italic toggle="yes">MYB</italic> protooncogene on chromosome 6q to the <italic toggle="yes">NFIB</italic> gene on chromosome 9p, resulting in an overexpression of <italic toggle="yes">MYB-NFIB</italic> fusion oncogene and worse prognosis.<xref ref-type="bibr" rid="article-31299.r73">[73]</xref><xref ref-type="bibr" rid="article-31299.r74">[74]</xref><xref ref-type="bibr" rid="article-31299.r75">[75]</xref>&#x000a0;ACC develops from tumorigenesis of cells responsible for acinar development, namely the reserve cells of the intercalated ducts and terminal tubules. In mice studies, inactivation of <italic toggle="yes">PTEN</italic> and <italic toggle="yes">Apc</italic> led to an upregulation of <italic toggle="yes">mTOR</italic> and <italic toggle="yes">Wnt</italic> signaling, which increased the incidence of ACC.<xref ref-type="bibr" rid="article-31299.r76">[76]</xref>&#x000a0;ACC in humans has also been found to have a higher&#x000a0;mTOR expression than&#x000a0;other salivary malignancies.<xref ref-type="bibr" rid="article-31299.r8">[8]</xref></p>
        <p>The presence of biological receptors in salivary gland malignancies has recently come under investigation. Tyrosine kinase receptors such as the epidermal growth factor receptor (EGFR) are present in up to 71% of all salivary gland cancers.<xref ref-type="bibr" rid="article-31299.r77">[77]</xref>&#x000a0;Epidermal growth factor receptor 2 (HER2) is present in cancers derived from excretory ducts such as the salivary ducts.<xref ref-type="bibr" rid="article-31299.r78">[78]</xref>&#x000a0;<italic toggle="yes">C-kit</italic> is expressed in malignancies derived from the intercalated ducts of salivary glands such as AdCC.<xref ref-type="bibr" rid="article-31299.r79">[79]</xref>&#x000a0;Androgen receptor expression has been found in salivary duct carcinoma and adenocarcinoma.<xref ref-type="bibr" rid="article-31299.r77">[77]</xref>&#x000a0;Gonadal hormone receptors such as the estrogen and progesterone receptors have been found in benign and malignant salivary gland neoplasms.<xref ref-type="bibr" rid="article-31299.r80">[80]</xref>&#x000a0;Salivary duct carcinoma tends to overexpress <italic toggle="yes">erb-B2</italic>, which has been associated with a worse prognosis.<xref ref-type="bibr" rid="article-31299.r81">[81]</xref><xref ref-type="bibr" rid="article-31299.r82">[82]</xref>&#x000a0;Epigenetic mutations involving DNA promoter methylation of tumor suppressor genes can lead to transcriptional inactivation and increase both the risk of salivary duct carcinoma and the transformation of pleomorphic adenoma into carcinoma ex pleomorphic adenoma.<xref ref-type="bibr" rid="article-31299.r83">[83]</xref><xref ref-type="bibr" rid="article-31299.r84">[84]</xref>&#x000a0;The presence of SCC in the salivary glands is suspected to arise from several sources, including 1) malignant squamous portion of MEC, 2) metastasis from a cutaneous or mucosal head and neck source, 3) metastasis from distant primary carcinoma, or 4) primary squamous cell carcinoma.<xref ref-type="bibr" rid="article-31299.r19">[19]</xref></p>
        <p>Approximately 4.4% to 5.2% of malignant melanoma of the parotid cases do not have a&#x000a0;primary source.<xref ref-type="bibr" rid="article-31299.r57">[57]</xref><xref ref-type="bibr" rid="article-31299.r58">[58]</xref>&#x000a0;They are suspected to be due to a metastatic cutaneous source that has subsequently regressed or metastases from an unusual mucosal site such as the sclera, nasal cavity, paranasal sinuses, or throat.<xref ref-type="bibr" rid="article-31299.r85">[85]</xref><xref ref-type="bibr" rid="article-31299.r22">[22]</xref><xref ref-type="bibr" rid="article-31299.r86">[86]</xref><xref ref-type="bibr" rid="article-31299.r85">[85]</xref>&#x000a0;In addition, although rare, primary melanoma can develop in the parotid gland. Melanoblasts can&#x000a0;migrate into the gland during the invagination of oral epithelium during parotid gland development.<xref ref-type="bibr" rid="article-31299.r87">[87]</xref>&#x000a0;In an autopsy case, Takeda et al&#x000a0;discovered the presence of melanocytes in the basal and suprabasal layers of the interlobular ducts, which can serve as the cells of origin for primary melanoma of the parotid.<xref ref-type="bibr" rid="article-31299.r25">[25]</xref>&#x000a0;The&#x000a0;development of lymphoma from Sjogren syndrome is theorized to be due to prolonged B-cell activity and survival. Sjogren syndrome is associated with excessive expression of cytokines, chemokines, and inflammatory factors such as interferon (IFN) and B-cell activating factor.<xref ref-type="bibr" rid="article-31299.r88">[88]</xref><xref ref-type="bibr" rid="article-31299.r89">[89]</xref>&#x000a0;The B-cell activating factor induces the migration of T and B lymphocytes into the salivary glands to create an autoimmune reaction. The B cells start producing SS-A and SS-B antibodies, which are used to diagnose Sjogren syndrome.<xref ref-type="bibr" rid="article-31299.r27">[27]</xref> Although the exact pathway is unknown, the constant activity of these B cells is believed to be the inciting event of lymphomagenesis in Sjogren syndrome.<xref ref-type="bibr" rid="article-31299.r90">[90]</xref></p>
      </sec>
      <sec id="article-31299.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p><bold>MEC</bold>&#x000a0;is a non-encapsulated, poorly circumscribed mass with cystic components that can often be mistaken for mucoceles.<xref ref-type="bibr" rid="article-31299.r91">[91]</xref> MEC can comprise up to 6 different types of cells, including maternal, intermediate, epidermoid, clear, columnar, and mucous. Maternal cells are the progenitors for the other cell types and have small, round nuclei with scant, basophilic cytoplasm. Intermediate cells can develop into either glandular or epidermoid cells. Epidermoid cells present with homogenous cytoplasm and occasional keratin pearls and intracellular bridges. Clear cells have watery cytoplasm with small, central nuclei. Columnar cells resemble the secretory duct cells of the salivary gland and transform into mucous cells. Mucous cells have small nuclei at the periphery with foamy, reticular cytoplasm and can occasionally develop a signet-ring appearance.<xref ref-type="bibr" rid="article-31299.r91">[91]</xref><xref ref-type="bibr" rid="article-31299.r92">[92]</xref>&#x000a0;MEC can occur as low, intermediate, or high-grade disease depending on the&#x000a0;quantity of aggressive epidermoid tissue. Low-grade MEC has well-formed cystic spaces with high glandular composition. The intermediate grade tends to have more solid nests of epidermoid and intermediate cells with less prominent cystic spaces. High-grade MEC has limited mucous cells with large amounts of solid, squamous cells that can often be misdiagnosed as squamous cell carcinoma.<xref ref-type="bibr" rid="article-31299.r93">[93]</xref><xref ref-type="bibr" rid="article-31299.r94">[94]</xref>&#x000a0;When MEC arises in the submandibular gland, it behaves aggressively regardless of its histologic grading.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref>&#x000a0;</p>
        <p><bold>AdCC</bold>&#x000a0;presents as a non-encapsulated, well-circumscribed mass with biphasic ductal and myoepithelial components and&#x000a0;3 distinct patterns: tubular, cribriform, and solid.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref><xref ref-type="bibr" rid="article-31299.r30">[30]</xref>&#x000a0;The cribriform variant presents a &#x0201c;Swiss-cheese&#x0201d; appearance, containing cylindrical pseudocysts lined with epithelial cells and hyaline material.&#x000a0;The tubular variant consists of ducts lined by 1 to 2 layers of myoepithelial-like cells.&#x000a0;The solid variant has solid epithelial islands with central areas of necrosis.<xref ref-type="bibr" rid="article-31299.r28">[28]</xref><xref ref-type="bibr" rid="article-31299.r95">[95]</xref> The solid variant is the most aggressive of the&#x000a0;3 and tends to hematogenous metastasis in 40-60% of cases with perineural invasion along the palatine branches, through which it can extend into the pterygopalatine fossa and cavernous sinus.<xref ref-type="bibr" rid="article-31299.r95">[95]</xref><xref ref-type="bibr" rid="article-31299.r96">[96]</xref><xref ref-type="bibr" rid="article-31299.r97">[97]</xref></p>
        <p><bold>ACC</bold>&#x000a0;presents several growth patterns, including solid (most common), papillary-cystic, follicular, and microcystic.<xref ref-type="bibr" rid="article-31299.r98">[98]</xref>&#x000a0;Microscopically, it appears well-circumscribed by a lymphoid stroma or a capsule. Individual cells can be granulated serous-type cells, primitive tubule cells, or undifferentiated polymorphous cells.<xref ref-type="bibr" rid="article-31299.r98">[98]</xref><xref ref-type="bibr" rid="article-31299.r99">[99]</xref>&#x000a0;Although&#x000a0;ACC is usually considered a low-grade malignancy, it can undergo high-grade transformation into high-grade adenocarcinoma or undifferentiated carcinoma and present with complete loss of acinar differentiation, desmoplasia, tumor necrosis, frequent mitosis, and cervical or distant metastasis.<xref ref-type="bibr" rid="article-31299.r100">[100]</xref><xref ref-type="bibr" rid="article-31299.r101">[101]</xref><xref ref-type="bibr" rid="article-31299.r102">[102]</xref></p>
        <p><bold>CExPA</bold>&#x000a0;arises from an existing pleomorphic adenoma and can histologically resemble salivary duct carcinoma, adenocarcinoma, or undifferentiated carcinoma.<xref ref-type="bibr" rid="article-31299.r48">[48]</xref><xref ref-type="bibr" rid="article-31299.r103">[103]</xref>&#x000a0;Microscopically, it can present with varying extents of invasion, including intracapsular, minor extracapsular (&#x0003c;5 mm beyond the capsule), and wide extracapsular (&#x0003e;5 mm beyond the capsule). The wide extracapsular variant presents a high risk of recurrence and distant metastasis.<xref ref-type="bibr" rid="article-31299.r30">[30]</xref><xref ref-type="bibr" rid="article-31299.r48">[48]</xref><xref ref-type="bibr" rid="article-31299.r103">[103]</xref></p>
        <p><bold>PLGA</bold>&#x000a0;presents as an unencapsulated mass predominantly seen on the palate, with a high concentration of minor salivary glands. Histologically, it can resemble AdCC and has an infiltrative growth pattern with a mixture of solid, cribriform, tubular, and cystic patterns.<xref ref-type="bibr" rid="article-31299.r104">[104]</xref><xref ref-type="bibr" rid="article-31299.r105">[105]</xref><xref ref-type="bibr" rid="article-31299.r106">[106]</xref></p>
        <p><bold>Salivary Duct Carcinoma</bold> is similar in histology to high-grade duct carcinoma of the breast.<xref ref-type="bibr" rid="article-31299.r107">[107]</xref>&#x000a0;It can present with cribriform, solid, cystic, or papillary growth patterns.<xref ref-type="bibr" rid="article-31299.r30">[30]</xref></p>
        <p><bold>SCC</bold>&#x000a0;presents with intracellular keratinization, intercellular bridging, and keratin-pearl formation without any intracellular mucin.<xref ref-type="bibr" rid="article-31299.r92">[92]</xref></p>
        <p><bold>Melanoma</bold> of the parotid presents with large, rounded eosinophilic cells with a pleomorphic nucleus and prominent nuclei.<xref ref-type="bibr" rid="article-31299.r24">[24]</xref><xref ref-type="bibr" rid="article-31299.r108">[108]</xref>&#x000a0;To be considered a primary melanoma of the parotid, the melanoma tumor must be intra-parotid with no lymph node tissue present and&#x000a0;no&#x000a0;prior excisions or evidence of malignant lesions elsewhere in the body.<xref ref-type="bibr" rid="article-31299.r109">[109]</xref>&#x000a0;</p>
        <p><bold>NHL</bold>&#x000a0;of the major salivary gland presents with atypical lymphocytes with invasion into the adjacent ductal epithelium, lymphoepithelial lesions, and lymphoid follicles or germinal centers.<xref ref-type="bibr" rid="article-31299.r66">[66]</xref><xref ref-type="bibr" rid="article-31299.r110">[110]</xref><xref ref-type="bibr" rid="article-31299.r111">[111]</xref></p>
        <p>A high-grade transformation is a rare event involving a well-differentiated tumor's transformation into an aggressive, poorly differentiated, high-grade morphology that lacks any original histologic characteristics. It can be seen in AdCC, ACC, PLGA, and MEC.<xref ref-type="bibr" rid="article-31299.r112">[112]</xref></p>
      </sec>
      <sec id="article-31299.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients often present with a history of a palpable mass that localizes to the region of the salivary glands. A detailed history should be obtained, including pain symptoms, onset and duration of the mass, growth rate, associated swallowing difficulties, and occurrence of facial weakness. Past medical history, including a history of previous skin cancers of the head and neck, surgical history, family history of malignancies, and social risk factors such as smoking, past radiation exposure, and occupational exposures, should be elicited. Physical exam should include a comprehensive head and neck exam focused on the salivary glands, cranial nerves, and cervical nodes. Malignant tumors can present as painless, fixed, or mobile masses, so distinguishing from benign tumors may be hard to distinguish. Advanced malignancies may present with pain, palatal fullness, parapharyngeal fullness, trismus, overlying skin ulceration, or fistulas.&#x000a0;Minor salivary gland tumors can present as submucosal oral swelling with ulceration or with nasal obstruction and bleeding if they occur in the nasal cavity or nasopharynx. Minor salivary gland tumors in the pharynx or larynx can cause dysphagia, odynophagia, airway obstruction, vocal hoarseness, and dyspnea on exertion.<xref ref-type="bibr" rid="article-31299.r113">[113]</xref>&#x000a0;Rapid growth, pain, facial nerve paresis, and cervical lymphadenopathy are concerning signs of malignancy.<xref ref-type="bibr" rid="article-31299.r38">[38]</xref></p>
        <p>Parotid malignancies presenting as large, fixed preauricular masses can be associated with cervical lymph node metastasis. Facial nerve paralysis can be seen in up to 12&#x000a0;to 15% of cases and is often associated with AdCC, MEC, and salivary duct carcinoma.<xref ref-type="bibr" rid="article-31299.r114">[114]</xref>&#x000a0;Submandibular malignancies often present as painless neck masses in the submandibular triangle of the neck. Malignant lesions here are often firm and lobulated, may be fixed to skin or deeper tissues, and may exhibit associated paralysis of the facial nerve's lingual nerve, hypoglossal nerve, or marginal mandibular branch.<xref ref-type="bibr" rid="article-31299.r115">[115]</xref>&#x000a0;Sublingual gland malignancies can present as painless, non-ulcerated masses on the floor of the mouth, although about 50% of cases can present with pain and numbness.<xref ref-type="bibr" rid="article-31299.r116">[116]</xref>&#x000a0;As previously mentioned, minor salivary gland malignant tumors&#x000a0;tend to present along the upper aerodigestive tract as asymptomatic submucosal masses, rare ulceration, and occasional upper airway narrowing.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref></p>
        <p>Specific presentations peculiar to the salivary malignancies include:</p>
        <list list-type="bullet">
          <list-item>
            <p>MEC often presents as an asymptomatic, firm mass with occasional pain and facial paralysis.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref> First-bite syndrome has been associated with MEC.<xref ref-type="bibr" rid="article-31299.r114">[114]</xref></p>
          </list-item>
          <list-item>
            <p>AdCC presents as a slow-growing, solid mass with pain secondary to perineural and extra-parenchymal invasion. Cervical lymph node metastasis occurs at a rate of 20% at presentation and is more common with submandibular tumors.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref>&#x000a0;First-bite syndrome has also been associated with AdCC.<xref ref-type="bibr" rid="article-31299.r117">[117]</xref></p>
          </list-item>
          <list-item>
            <p>ACC presents as a slow-growing, solitary mass with occasional pain.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref></p>
          </list-item>
          <list-item>
            <p>PLGA presents as a well-circumscribed mass with pain; ulceration is present in 8% of cases.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref></p>
          </list-item>
          <list-item>
            <p>CExPA commonly presents in a patient with a history of a long-standing parotid mass characterized by a sudden increase in size. It can be associated with pain and nerve palsy in up to 30% of cases.<xref ref-type="bibr" rid="article-31299.r118">[118]</xref></p>
          </list-item>
          <list-item>
            <p>Salivary duct carcinoma presents as a firm, poorly defined mass with the invasion of the surrounding glandular and soft tissue, resulting in associated pain and facial nerve palsy. More than 50% of patients display cervical metastasis at initial presentation.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref></p>
          </list-item>
          <list-item>
            <p>SCC can present as a long-standing mass with sudden rapid growth, pain, facial nerve palsy, or overlying skin ulceration.<xref ref-type="bibr" rid="article-31299.r119">[119]</xref></p>
          </list-item>
          <list-item>
            <p>Melanoma of the parotid gland can present as an indolent and firm preauricular mass with infiltrative growth resulting in pain, facial nerve palsy, and overlying dermal changes such as ulceration and erythema.<xref ref-type="bibr" rid="article-31299.r19">[19]</xref><xref ref-type="bibr" rid="article-31299.r120">[120]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>NHL of the salivary gland can present with unilateral or bilateral swelling of the parotid gland, cervical lymphadenopathy, splenomegaly, vasculitis, and palpable purpura.<xref ref-type="bibr" rid="article-31299.r27">[27]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31299.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Evaluation Options Include</bold>
</p>
        <p><bold>Ultrasound</bold> is the first non-invasive option for evaluating major salivary gland tumors, especially superficial parotid lesions. It can help localize tumors, distinguish solid masses from cystic collections, and help guide fine-needle aspiration biopsy. Heterogenous echogenicity, local invasion, poorly defined margins, and lymphadenopathy are sonographic signs of malignancy.<xref ref-type="bibr" rid="article-31299.r121">[121]</xref><xref ref-type="bibr" rid="article-31299.r122">[122]</xref></p>
        <p><bold>Computerized tomography (CT).</bold> Conventional CT can evaluate tumor extent, bony infiltration, and lymphadenopathy. However, it is limited by the dental artifact and has a poor soft-tissue resolution, especially for MEC, AdCC, and ACC, leading to underestimating the lesion.<xref ref-type="bibr" rid="article-31299.r30">[30]</xref></p>
        <p><bold>Magnetic resonance imaging (MRI)</bold>. MRI is recommended to assess tumor extent, soft tissue invasion, and nerve involvement for lesions in the deep parotid lobe, sublingual glands, and minor salivary glands. MRI can be performed to detect the facial nerve branches and their interface with surrounding soft tissue for surgical planning. MRI has a higher sensitivity and specificity than CT in detecting perineural spread, especially for AdCC.<xref ref-type="bibr" rid="article-31299.r123">[123]</xref>&#x000a0;Heterogenous contrast enhancement, local soft tissue invasion, poorly defined margins, hypointensity on T2-weighted imaging, and lymphadenopathy are characteristics of malignancy.<xref ref-type="bibr" rid="article-31299.r121">[121]</xref><xref ref-type="bibr" rid="article-31299.r124">[124]</xref>&#x000a0;Diffusion-weighted MRI can quantify the diffusion properties of water in tumor tissue into the apparent diffusion coefficient (ADC) that can help distinguish malignant tumors from benign tumors. Salivary gland malignancies have significantly smaller ADC than benign tumors, although the ADC of Warthin&#x02019;s tumor is even smaller than that of malignancies due to excessive lymphoid tissue resembling lymphoma.<xref ref-type="bibr" rid="article-31299.r125">[125]</xref><xref ref-type="bibr" rid="article-31299.r126">[126]</xref></p>
        <p><bold>Positron emission tomography (PET). </bold>The role of PET is to detect locoregional and distant metastasis. Compared with conventional CT, PET is more accurate in demonstrating tumor extension, nodal involvement, local recurrence, and distant metastasis due to the tissues&#x02019; higher standardized uptake values.<xref ref-type="bibr" rid="article-31299.r127">[127]</xref><xref ref-type="bibr" rid="article-31299.r128">[128]</xref>&#x000a0;However, PET cannot differentiate between benign and malignant tumors because benign tumors (such as pleomorphic adenoma and Warthin&#x02019;s tumor) exhibit high glucose uptake values due to cells with high mitochondrial content.<xref ref-type="bibr" rid="article-31299.r129">[129]</xref><xref ref-type="bibr" rid="article-31299.r130">[130]</xref></p>
        <p><bold>Biopsy.</bold> Imaging is unable to completely distinguish between benign and malignant lesions. Therefore, obtaining histological samples is key to determining the next steps in management. An incisional biopsy can be used for minor salivary glands in the oral cavity but is not recommended for parotid lesions due to the risk of damage to the facial nerve and the possibility of tumor seeding. Hence, ultrasound-guided fine-needle aspiration (FNA) is preferred.<xref ref-type="bibr" rid="article-31299.r131">[131]</xref>&#x000a0;FNA's sensitivity and specificity in differentiating between benign and malignant lesions are 80% and 97%, respectively.<xref ref-type="bibr" rid="article-31299.r132">[132]</xref> However, FNA may falter in determining the specific malignant subtype and tumor grade.<xref ref-type="bibr" rid="article-31299.r133">[133]</xref>&#x000a0;</p>
        <p>An ultrasound-guided core needle biopsy can obtain larger tissue specimens with histologic architecture, improving tumor grade recognition to allow further subtyping. The diagnosis and classification of the specific type of lymphoma of the salivary glands require histological cellular architecture.<xref ref-type="bibr" rid="article-31299.r134">[134]</xref> Disadvantages of core biopsy include more pain, increased risk of facial nerve injury, and hematoma.<xref ref-type="bibr" rid="article-31299.r135">[135]</xref>&#x000a0;The intraoperative frozen section has a sensitivity and specificity of 90% and 99%, distinguishing between benign and malignant lesions.<xref ref-type="bibr" rid="article-31299.r136">[136]</xref></p>
      </sec>
      <sec id="article-31299.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Surgical excision with negative margins is the mainstay of treatment for all salivary gland malignancies. Despite preoperative attempts to obtain a diagnosis through a needle biopsy, histological diagnosis may sometimes not be available until surgery, when frozen specimens can be analyzed. The extent of surgery and the need for neck dissection or adjuvant radiotherapy depend on the malignancy's subtype, grade, and stage.<xref ref-type="bibr" rid="article-31299.r30">[30]</xref>&#x000a0;Adjuvant radiation therapy is recommended after surgical excision to improve locoregional control in cases with positive margins, cervical metastases, advanced cancer stage, aggressive histology or grade, perineural invasion, lymphovascular invasion, or extra-glandular extension.<xref ref-type="bibr" rid="article-31299.r137">[137]</xref><xref ref-type="bibr" rid="article-31299.r138">[138]</xref><xref ref-type="bibr" rid="article-31299.r139">[139]</xref><xref ref-type="bibr" rid="article-31299.r140">[140]</xref><xref ref-type="bibr" rid="article-31299.r141">[141]</xref>&#x000a0;Primary&#x000a0;radiation therapy is usually reserved for patients with unresectable disease, metastatic disease, or poor surgical candidacy.<xref ref-type="bibr" rid="article-31299.r142">[142]</xref><xref ref-type="bibr" rid="article-31299.r143">[143]</xref>&#x000a0;Chemotherapy and biologically targeted therapy are the standard of care for lymphoma but have limited roles in the other malignancies, often utilized in the palliative setting with partial response.<xref ref-type="bibr" rid="article-31299.r27">[27]</xref><xref ref-type="bibr" rid="article-31299.r34">[34]</xref>&#x000a0;More prospective research and clinical trials are needed before chemotherapy and targeted therapies become routine clinical tools in managing salivary malignancies.<xref ref-type="bibr" rid="article-31299.r34">[34]</xref><xref ref-type="bibr" rid="article-31299.r113">[113]</xref></p>
      </sec>
      <sec id="article-31299.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for&#x000a0;malignant salivary gland tumors are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Benign salivary lesions (pleomorphic adenoma, myoepithelioma, basal cell adenoma, Warthin's tumor, oncocytoma, canalicular adenoma, sebaceous adenoma, lymphadenoma, inverted ductal papilloma, intraductal papilloma, cystadenoma)</p>
          </list-item>
          <list-item>
            <p>Benign salivary cysts</p>
          </list-item>
          <list-item>
            <p>Sialadenitis</p>
          </list-item>
          <list-item>
            <p>Sialoliths</p>
          </list-item>
          <list-item>
            <p>Lymphadenopathy (from infectious or inflammatory causes)</p>
          </list-item>
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
          <list-item>
            <p>Mononucleosis</p>
          </list-item>
          <list-item>
            <p>Chronic Sclerosing Sialadenitis (K&#x000fc;ttner tumor, which is more common in the submandibular gland)</p>
          </list-item>
          <list-item>
            <p>First Branchial cleft cysts</p>
          </list-item>
          <list-item>
            <p>Lymphoepithelial cysts (especially in immunocompromised patients such as HIV patients)</p>
          </list-item>
          <list-item>
            <p>Metastases from tumors of other body sites</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31299.s11" sec-type="Surgical Oncology">
        <title>Surgical Oncology</title>
        <p>Wide local excision is the first-line treatment for all malignant salivary gland tumors. Superficial parotidectomy is the standard treatment of choice for the removal of benign and malignant parotid tumors in the superficial lobe with preservation of the facial nerve.<xref ref-type="bibr" rid="article-31299.r38">[38]</xref> The procedure involves elevating a skin flap over the parotid capsule, identifying the facial nerve trunk and dissecting along all its branches, with preservation of the facial nerve branches that are uninvolved by malignancy, and subsequent removal of the superficial lobe of the parotid while maintaining the integrity of the tumor pseudocapsule.<xref ref-type="bibr" rid="article-31299.r38">[38]</xref> A total parotidectomy is required for advanced or deep lobe lesions. If the facial nerve is infiltrated, a radical total parotidectomy with facial nerve sacrifice and reconstruction is required.<xref ref-type="bibr" rid="article-31299.r144">[144]</xref> For tumors abutting the facial nerve, the tumor can be peeled off and followed with adjuvant radiotherapy to clear microscopic disease.<xref ref-type="bibr" rid="article-31299.r144">[144]</xref><xref ref-type="bibr" rid="article-31299.r145">[145]</xref></p>
        <p>The disadvantages of superficial parotidectomy include excessive resection of parotid tissue, leading to loss of parotid function, and the risk of facial nerve paralysis due to complete facial nerve dissection. For low-grade or smaller lesions located in the lateral or latero-inferior part of the superficial lobe, the partial superficial parotidectomy, where the tumor is resected with a normal margin of parotid tissue with the facial nerve dissected only in the vicinity of the tumor, has been proposed.<xref ref-type="bibr" rid="article-31299.r146">[146]</xref><xref ref-type="bibr" rid="article-31299.r147">[147]</xref>&#x000a0;A comparison of the&#x000a0;2 techniques was studied by Roh et al&#x000a0;who found partial superficial parotidectomy to have better cosmesis, improved sensory and salivary functions, less facial nerve weakness, and no difference in recurrence rate.<xref ref-type="bibr" rid="article-31299.r148">[148]</xref>&#x000a0;Excision of the entire submandibular gland should be performed for any submandibular malignant lesions or if the final diagnosis cannot be confirmed.<xref ref-type="bibr" rid="article-31299.r149">[149]</xref> The procedure involves elevating subplatysmal flaps over the submandibular gland, identifying and ligating the facial vessels and submandibular duct, preserving the lingual and hypoglossal nerves, and removing the gland while maintaining the integrity of the tumor.</p>
        <p>Cervical (neck) metastases in salivary gland malignancies range from 10% to 40%, depending on tumor grade, location, histologic subtype, and size.<xref ref-type="bibr" rid="article-31299.r150">[150]</xref><xref ref-type="bibr" rid="article-31299.r151">[151]</xref>&#x000a0;Cervical metastasis is present in 35% to 62% of high-grade tumors and 0% to 15% of low-grade tumors.<xref ref-type="bibr" rid="article-31299.r152">[152]</xref>&#x000a0;Minor salivary gland tumors in the pharynx or larynx present with neck metastases in 30 to 47% of cases.<xref ref-type="bibr" rid="article-31299.r153">[153]</xref><xref ref-type="bibr" rid="article-31299.r154">[154]</xref>&#x000a0;Histologies such as salivary duct carcinoma, adenocarcinoma, or high-grade MEC have a rate of neck metastasis ranging from 40% to 80%.<xref ref-type="bibr" rid="article-31299.r150">[150]</xref><xref ref-type="bibr" rid="article-31299.r153">[153]</xref><xref ref-type="bibr" rid="article-31299.r155">[155]</xref><xref ref-type="bibr" rid="article-31299.r156">[156]</xref>&#x000a0;In patients with a clinically negative neck, occult metastasis has been identified in 12% to 50% of cases.<xref ref-type="bibr" rid="article-31299.r151">[151]</xref><xref ref-type="bibr" rid="article-31299.r157">[157]</xref> The presence of occult metastasis has been associated with tumor grade, advanced patient age, lymphatic invasion, and extra-parotid tumor extension.<xref ref-type="bibr" rid="article-31299.r158">[158]</xref></p>
        <p>Chisholm et al analyzed the anatomical distributions of positive nodal metastasis in parotid cancers showing only ipsilateral involvement. They found up to 28% in level I, 59% in level II, 52% in level II, 38% in level IV, and 42% in level IV. About 33% of cases displayed skip metastasis to level V, which led to the recommendation of a complete ipsilateral neck dissection from level I-V for parotid malignancies with positive neck disease.<xref ref-type="bibr" rid="article-31299.r159">[159]</xref><xref ref-type="bibr" rid="article-31299.r152">[152]</xref><xref ref-type="bibr" rid="article-31299.r160">[160]</xref>&#x000a0;In malignancies with clinically negative neck disease, elective neck dissection is recommended for high-grade T3/T4 tumors, facial nerve paralysis, age &#x0003e;54 years, extra-glandular extension, and lymphatic invasion.<xref ref-type="bibr" rid="article-31299.r71">[71]</xref><xref ref-type="bibr" rid="article-31299.r161">[161]</xref></p>
        <p>For submandibular and minor salivary gland carcinomas, clinical cervical metastasis is present in 8&#x000a0;to 20% of cases. It increases to 41% after neck dissection, with the most frequently involved nodes occurring in levels I-III for submandibular gland malignancies.<xref ref-type="bibr" rid="article-31299.r42">[42]</xref><xref ref-type="bibr" rid="article-31299.r139">[139]</xref><xref ref-type="bibr" rid="article-31299.r151">[151]</xref>&#x000a0;Thus, a supra-omohyoid neck dissection (level I to III) is recommended.<xref ref-type="bibr" rid="article-31299.r115">[115]</xref><xref ref-type="bibr" rid="article-31299.r153">[153]</xref><xref ref-type="bibr" rid="article-31299.r162">[162]</xref>&#x000a0;Minor salivary gland carcinomas from the pharynx or larynx should undergo neck dissection from levels II to IV.<xref ref-type="bibr" rid="article-31299.r154">[154]</xref></p>
      </sec>
      <sec id="article-31299.s12" sec-type="Radiation Oncology">
        <title>Radiation Oncology</title>
        <p>Radiation therapy (RT) to the primary site is recommended in the postoperative or adjuvant setting to improve locoregional control and survival, especially in high-grade histology, advanced stage of the disease, positive or close margins, perineural invasion, lymphovascular invasion, cervical lymph node metastases, or extra-glandular extension.<xref ref-type="bibr" rid="article-31299.r137">[137]</xref><xref ref-type="bibr" rid="article-31299.r138">[138]</xref><xref ref-type="bibr" rid="article-31299.r139">[139]</xref><xref ref-type="bibr" rid="article-31299.r140">[140]</xref><xref ref-type="bibr" rid="article-31299.r141">[141]</xref>&#x000a0;A total dose of 60-66 Gy divided into daily fractions of 2 Gy over 6 weeks has been recommended. Elective neck radiation for clinically negative neck disease is optional. Positive neck disease can be irradiated with 50-60 Gy.<xref ref-type="bibr" rid="article-31299.r113">[113]</xref>&#x000a0;Studies show 10-year local control rates ranging from 83% to 91% for combining surgery and adjuvant&#x000a0;radiation therapy in advanced-stage disease.<xref ref-type="bibr" rid="article-31299.r139">[139]</xref><xref ref-type="bibr" rid="article-31299.r163">[163]</xref><xref ref-type="bibr" rid="article-31299.r164">[164]</xref></p>
        <p>Primary&#x000a0;radiation therapy is advised only in selective scenarios, including unresectable disease, poor surgical candidacy, unacceptable functional and cosmetic comorbidities from surgery, and palliation.<xref ref-type="bibr" rid="article-31299.r139">[139]</xref><xref ref-type="bibr" rid="article-31299.r143">[143]</xref>&#x000a0;Mendenhall et al. showed that the 10-year locoregional control rate in the setting of primary&#x000a0;radiation therapy was dependent on the disease stage, ranging from 70% for stage I-III down to 24% for stage IV. Less than 20% of patients with stage IV disease are cured with&#x000a0;radiation therapy alone.<xref ref-type="bibr" rid="article-31299.r143">[143]</xref> Neutron therapy has better locoregional control rates than photon therapy in unresectable cases, but there appears to be no difference in long-term survival.<xref ref-type="bibr" rid="article-31299.r165">[165]</xref></p>
      </sec>
      <sec id="article-31299.s13" sec-type="Medical Oncology">
        <title>Medical Oncology</title>
        <p>Chemotherapy is the mainstay of treatment for lymphoma of the salivary gland. Patients with MALT lymphoma are commonly treated with rituximab, 2-chlorodeoxyadenosine, fludarabine, and chlorambucil-cyclophosphamide.<xref ref-type="bibr" rid="article-31299.r134">[134]</xref>&#x000a0; Rituximab is a chimeric monoclonal antibody that binds&#x000a0;to the surface CD20 proteins of B cells, triggering cellular death.<xref ref-type="bibr" rid="article-31299.r27">[27]</xref>&#x000a0;For cases of DLBCL transformation, the standard chemotherapeutic regimen is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) with rituximab.<xref ref-type="bibr" rid="article-31299.r166">[166]</xref></p>
        <p>The benefit of chemotherapy is limited for other salivary gland malignancies. Combining chemotherapeutic agents (such as carboplatin, paclitaxel, fluorouracil, and hydroxyurea) with adjuvant radiation has shown moderate benefit with 5-year locoregional control rates of 90% to 95% reported in some studies. However,&#x000a0;there was no overall survival benefit compared with non-responding patients.<xref ref-type="bibr" rid="article-31299.r167">[167]</xref><xref ref-type="bibr" rid="article-31299.r168">[168]</xref><xref ref-type="bibr" rid="article-31299.r169">[169]</xref>&#x000a0;Other studies have failed to demonstrate any significant locoregional control or survival benefit in incorporating chemotherapy into primary or adjuvant RT.<xref ref-type="bibr" rid="article-31299.r34">[34]</xref><xref ref-type="bibr" rid="article-31299.r170">[170]</xref><xref ref-type="bibr" rid="article-31299.r171">[171]</xref>&#x000a0;In patients who are not surgical or radiation candidates, palliative chemotherapy involving cisplatin, paclitaxel, and gemcitabine has been shown to have a partial response in 20&#x000a0;to 25% of non-AdCC cases and &#x0003c;10% of AdCC cases.<xref ref-type="bibr" rid="article-31299.r172">[172]</xref><xref ref-type="bibr" rid="article-31299.r173">[173]</xref></p>
        <p>Targeted therapies against <italic toggle="yes">C-Kit</italic> (Imatinib),&#x000a0;<italic toggle="yes">HER2</italic> (Trastuzumab), EGFR (Cetuximab), and mTOR (Temsirolimus) have gained popularity due to the expression of biological receptors in several malignant salivary tumors. However, response rates have not been superior. This is likely due to a discrepancy between protein overexpression and gene mutation and loss of tumor suppressor <italic toggle="yes">PTEN</italic> that interferes with target therapy responsiveness.<xref ref-type="bibr" rid="article-31299.r174">[174]</xref><xref ref-type="bibr" rid="article-31299.r175">[175]</xref><xref ref-type="bibr" rid="article-31299.r176">[176]</xref><xref ref-type="bibr" rid="article-31299.r177">[177]</xref><xref ref-type="bibr" rid="article-31299.r178">[178]</xref><xref ref-type="bibr" rid="article-31299.r179">[179]</xref></p>
      </sec>
      <sec id="article-31299.s14" sec-type="Staging">
        <title>Staging</title>
        <p>
<bold>Clinical Staging&#x000a0;</bold>
</p>
        <p>Major salivary gland carcinomas are staged according to the TNM system of the American Joint Committee on Cancer (AJCC) 8 edition.<xref ref-type="bibr" rid="article-31299.r113">[113]</xref><xref ref-type="bibr" rid="article-31299.r180">[180]</xref><xref ref-type="bibr" rid="article-31299.r181">[181]</xref></p>
        <table-wrap id="article-31299.table0" position="float" orientation="portrait">
          <table border="1" cellspacing="1" cellpadding="20">
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>T Category</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Tumor Size and Characteristics</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Tx</p>
</td>
                <td rowspan="1" colspan="1">
<p>Primary tumor cannot be assessed</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Tis</p>
</td>
                <td rowspan="1" colspan="1">
<p>Carcinoma in-situ</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>T0</p>
</td>
                <td rowspan="1" colspan="1">
<p>No evidence of primary</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>T1</p>
</td>
                <td rowspan="1" colspan="1">
<p>Tumor &#x0003c;2 cm without extra-parenchymal extension</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>T2</p>
</td>
                <td rowspan="1" colspan="1">
<p>Tumor 2-4 cm without extra-parenchymal extension</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>T3</p>
</td>
                <td rowspan="1" colspan="1">
<p>Tumor &#x0003e;4cm and or tumor has an extra-parenchymal extension</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>T4a</p>
</td>
                <td rowspan="1" colspan="1">
<p>Tumor invades skin, mandible, external auditory canal, and/or facial nerve</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>T4b</p>
</td>
                <td rowspan="1" colspan="1">
<p>Tumor invades the skull base, pterygoid plates, or encases the carotid artery</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Clinical Node Category</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Node Criteria</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>cNx</p>
</td>
                <td rowspan="1" colspan="1">
<p>Regional lymph node cannot be assessed</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>cN0</p>
</td>
                <td rowspan="1" colspan="1">
<p>No regional lymph node metastasis</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>cN1</p>
</td>
                <td rowspan="1" colspan="1">
<p>Ipsilateral single metastatic lymph node &#x0003c;3 cm and Extra-nodal extension (ENE) negative</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>cN2a</p>
</td>
                <td rowspan="1" colspan="1">
<p>Ipsilateral single metastatic node &#x0003e;3 cm but &#x0003c;6 cm, ENE negative</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>cN2b</p>
</td>
                <td rowspan="1" colspan="1">
<p>Metastatic multiple ipsilateral nodes &#x0003e;6 cm, ENE negative</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>cN2c</p>
</td>
                <td rowspan="1" colspan="1">
<p>Metastatic bilateral or contralateral lymph nodes &#x0003c;6 cm, ENE negative</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>cN3a</p>
</td>
                <td rowspan="1" colspan="1">
<p>Metastatic lymph node &#x0003c;6 cm, ENE negative</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>cN3b</p>
</td>
                <td rowspan="1" colspan="1">
<p>Metastasis in any lymph node with ENE positive</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Metastasis Category</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Metastasis Criteria</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Mx</p>
</td>
                <td rowspan="1" colspan="1">
<p>Metastasis cannot be assessed</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>M0</p>
</td>
                <td rowspan="1" colspan="1">
<p>No distant metastasis</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>M1</p>
</td>
                <td rowspan="1" colspan="1">
<p>Distant metastasis identified&#x000a0;</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Staging for NHL based on the Lugano classification.<xref ref-type="bibr" rid="article-31299.r182">[182]</xref></p>
        <table-wrap id="article-31299.table1" position="float" orientation="portrait">
          <table border="1" cellspacing="1" cellpadding="20">
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p>Stage</p>
</td>
                <td rowspan="1" colspan="1">
<p>Nodal Involvement</p>
</td>
                <td rowspan="1" colspan="1">
<p>Extra-nodal Involvement</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Stage 1</p>
</td>
                <td rowspan="1" colspan="1">
<p>1 node or group of adjacent nodes</p>
</td>
                <td rowspan="1" colspan="1">
<p>Single extra-nodal lesion without nodal involvement</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Stage 2</p>
</td>
                <td rowspan="1" colspan="1">
<p>2 or more nodal groups on the same side of the diaphragm</p>
</td>
                <td rowspan="1" colspan="1">
<p>Stage 1 or 2 with limited contiguous extra-nodal spread</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Stage 3</p>
</td>
                <td rowspan="1" colspan="1">
<p>Nodes on both sides of the diaphragm, nodes above diaphragm with spleen involvement</p>
</td>
                <td rowspan="1" colspan="1">
<p>N/A</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Stage 4</p>
</td>
                <td rowspan="1" colspan="1">
<p>Wide non-contiguous spread beyond lymph system to bone, liver, lung</p>
</td>
                <td rowspan="1" colspan="1">
<p>N/A</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-31299.s15" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Salivary gland malignancies have a wide spectrum of prognoses due to the heterogeneous array of histologies. In general, the prognosis of salivary malignancies is better for children and adolescents than adults due to lower frequencies of cervical metastasis, absence of local soft tissue invasion, and more differentiated histologies. The 5-year overall survival for children after surgical treatment is 85% compared with 60% for adults.<xref ref-type="bibr" rid="article-31299.r183">[183]</xref><xref ref-type="bibr" rid="article-31299.r184">[184]</xref> Regardless of malignant subtype, negative prognostic factors for survival include advanced age, high-stage disease, high-grade histology, cervical metastasis, male gender, presence of pain, facial nerve involvement, perineural invasion, local soft tissue invasion, positive or close margins, distant metastasis, and comorbidities.<xref ref-type="bibr" rid="article-31299.r143">[143]</xref><xref ref-type="bibr" rid="article-31299.r185">[185]</xref><xref ref-type="bibr" rid="article-31299.r186">[186]</xref><xref ref-type="bibr" rid="article-31299.r187">[187]</xref><xref ref-type="bibr" rid="article-31299.r188">[188]</xref><xref ref-type="bibr" rid="article-31299.r189">[189]</xref><xref ref-type="bibr" rid="article-31299.r190">[190]</xref><xref ref-type="bibr" rid="article-31299.r191">[191]</xref>&#x000a0;Smoking and alcohol statuses were controversial, with some studies showing no significant influence on overall survival or disease-free survival&#x000a0;<xref ref-type="bibr" rid="article-31299.r192">[192]</xref><xref ref-type="bibr" rid="article-31299.r193">[193]</xref>,&#x000a0;whereas other studies found them to be poor&#x000a0;prognostic factors.<xref ref-type="bibr" rid="article-31299.r3">[3]</xref><xref ref-type="bibr" rid="article-31299.r13">[13]</xref>&#x000a0;Distant metastasis most commonly involves the lungs (40% to 91%) followed by bone (13% to 40%), liver (4% to 19%), soft tissue (9%), distant nodal basins (8%), and the brain (4% to 7%).<xref ref-type="bibr" rid="article-31299.r194">[194]</xref> Distant metastasis is&#x000a0;the main cause of mortality for malignant salivary glands.<xref ref-type="bibr" rid="article-31299.r113">[113]</xref></p>
        <p>Overexpression of epidermal growth factor receptor (EGRF) and human epidermal growth factor receptor 2&#x000a0;(HER2) have been identified in several salivary gland malignancies, such as salivary duct carcinoma. They tend to predict a higher incidence of cervical metastasis and worse survival.<xref ref-type="bibr" rid="article-31299.r30">[30]</xref>&#x000a0;The absence of&#x000a0;<italic toggle="yes">c-kit</italic> expression in AdCC is correlated with poorer prognosis.<xref ref-type="bibr" rid="article-31299.r155">[155]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>MEC: Low-grade MEC, especially cases with the <italic toggle="yes">MECT1-MAML2</italic> gene fusion, have a good prognosis with a 5-year survival rate of more than 90%.&#x000a0;However, the high-grade squamous variant of MEC has a high tendency for recurrence, cervical metastasis, and distant metastasis, with 5-year survival as low as 30% to 41.6%.<xref ref-type="bibr" rid="article-31299.r187">[187]</xref><xref ref-type="bibr" rid="article-31299.r195">[195]</xref>&#x000a0;About 33% of patients with MEC were found to have regional metastasis, of which 85% exhibited a high-grade primary tumor.<xref ref-type="bibr" rid="article-31299.r196">[196]</xref>&#x000a0;The 5-year survival has been shown to range from 75% to 96%.<xref ref-type="bibr" rid="article-31299.r197">[197]</xref><xref ref-type="bibr" rid="article-31299.r198">[198]</xref><xref ref-type="bibr" rid="article-31299.r199">[199]</xref>&#x000a0;The overall 10-year survival rate for MEC is about 53%.<xref ref-type="bibr" rid="article-31299.r200">[200]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>AdCC: Distant metastasis in AdCC takes a prolonged course and is often more common than cervical metastasis.<xref ref-type="bibr" rid="article-31299.r41">[41]</xref> The rate of distant metastasis ranges from 25% to 55%, whereas the local recurrence rate ranges from 15% to 85%. Distant metastasis from submandibular AdCC most commonly involves the lungs, and regional metastasis from submandibular AdCC is more common than other major salivary glands due to the proximity of the draining lymph nodes.<xref ref-type="bibr" rid="article-31299.r200">[200]</xref><xref ref-type="bibr" rid="article-31299.r201">[201]</xref>&#x000a0;The 5-year survival rate cited in the literature is unreliably optimistic at 60% to 90% due to the prolonged, indolent growth pattern of AdCC that can ultimately result in poor disease-free survival of 10% to 20% at 10 to 15 years. The solid pattern histology has the worst prognosis.<xref ref-type="bibr" rid="article-31299.r36">[36]</xref><xref ref-type="bibr" rid="article-31299.r200">[200]</xref><xref ref-type="bibr" rid="article-31299.r202">[202]</xref><xref ref-type="bibr" rid="article-31299.r203">[203]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>ACC: Overall survival is influenced by male gender, age &#x0003e;45 years, tumor size larger than 3 cm, and presence of distant metastasis.<xref ref-type="bibr" rid="article-31299.r204">[204]</xref> Cervical neck metastasis occurs in 6-10% and distant metastasis in 12% to 15% of cases.<xref ref-type="bibr" rid="article-31299.r205">[205]</xref><xref ref-type="bibr" rid="article-31299.r206">[206]</xref><xref ref-type="bibr" rid="article-31299.r207">[207]</xref><xref ref-type="bibr" rid="article-31299.r208">[208]</xref>&#x000a0;The survival rate at 5-years is 75% to 96% and at 20-years is 56%.<xref ref-type="bibr" rid="article-31299.r99">[99]</xref><xref ref-type="bibr" rid="article-31299.r206">[206]</xref><xref ref-type="bibr" rid="article-31299.r209">[209]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>CExPA: CExPA&#x000a0;can display a wide range of recurrence and survival rates depending on the extent of differentiation and invasion. Tumors with wide extracapsular invasion beyond 5 mm of the capsule present a high risk of recurrence and distant metastasis.<xref ref-type="bibr" rid="article-31299.r30">[30]</xref><xref ref-type="bibr" rid="article-31299.r48">[48]</xref><xref ref-type="bibr" rid="article-31299.r103">[103]</xref>. Regional metastasis in CExPA reduces the 5-year survival rate from 67% to 16%.<xref ref-type="bibr" rid="article-31299.r210">[210]</xref>&#x000a0;Clinical neck metastasis is present in 33% of patients with CExPA, and occult neck metastasis in 16% of patients.<xref ref-type="bibr" rid="article-31299.r211">[211]</xref> The 5-year survival ranges from 30% to 96%, depending on the histology variant.<xref ref-type="bibr" rid="article-31299.r48">[48]</xref><xref ref-type="bibr" rid="article-31299.r212">[212]</xref>&#x000a0;The overall 10-year survival rate for CExPA is 62%.<xref ref-type="bibr" rid="article-31299.r200">[200]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>PLGA: Local recurrence is reported in 9-33% of cases, with cervical lymph node metastasis present in 6% to 35% of cases and distant metastasis at 1%.<xref ref-type="bibr" rid="article-31299.r213">[213]</xref> PLGA has an indolent growth pattern known to recur for decades after initial treatment.<xref ref-type="bibr" rid="article-31299.r49">[49]</xref>&#x000a0;The 5-year survival rate ranges from 75% to 100%.<xref ref-type="bibr" rid="article-31299.r213">[213]</xref><xref ref-type="bibr" rid="article-31299.r214">[214]</xref><xref ref-type="bibr" rid="article-31299.r215">[215]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Salivary duct carcinoma: Salivary duct carcinoma presents with perineural and lymphovascular invasion in 60% and 30% of cases, respectively.<xref ref-type="bibr" rid="article-31299.r30">[30]</xref> Cervical lymph node metastasis is seen in up to 60% of cases, with 50% of patients already having distant metastasis at the time of presentation.<xref ref-type="bibr" rid="article-31299.r155">[155]</xref><xref ref-type="bibr" rid="article-31299.r216">[216]</xref>&#x000a0;The 5-year overall survival ranges from 20% to 50%.<xref ref-type="bibr" rid="article-31299.r51">[51]</xref><xref ref-type="bibr" rid="article-31299.r113">[113]</xref><xref ref-type="bibr" rid="article-31299.r216">[216]</xref><xref ref-type="bibr" rid="article-31299.r113">[113]</xref><xref ref-type="bibr" rid="article-31299.r217">[217]</xref>&#x000a0;The majority of patients die within 3 years of diagnosis.<xref ref-type="bibr" rid="article-31299.r51">[51]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>SCC: The overall 5-year survival of primary SCC of the salivary glands is influenced based on tumor staging and ranges from 50% to 80% for early-stage tumors and 15% for advanced-stage tumors.<xref ref-type="bibr" rid="article-31299.r20">[20]</xref><xref ref-type="bibr" rid="article-31299.r21">[21]</xref><xref ref-type="bibr" rid="article-31299.r55">[55]</xref>&#x000a0;Advanced age,&#x000a0;facial palsy, and regional nodal metastasis were poor prognostic factors.<xref ref-type="bibr" rid="article-31299.r55">[55]</xref><xref ref-type="bibr" rid="article-31299.r218">[218]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Melanoma: The prognosis of melanoma&#x000a0;of unknown primary is controversial, with some studies stating no difference compared with typical melanoma at the same stage.<xref ref-type="bibr" rid="article-31299.r58">[58]</xref><xref ref-type="bibr" rid="article-31299.r86">[86]</xref>&#x000a0;However, Wang et al showed patients with salivary melanoma of unknown primary had improved 5-year survival at 38.5% compared with 14.2% for patients with known primary tumor sites.<xref ref-type="bibr" rid="article-31299.r22">[22]</xref>&#x000a0;Furthermore, melanoma patients with unknown primary sites were found to have a longer disease-free survival period (4.2 years vs. 2.6 years).<xref ref-type="bibr" rid="article-31299.r22">[22]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>NHL: Patients with MALT have a 3-year overall survival of 80%.<xref ref-type="bibr" rid="article-31299.r134">[134]</xref>&#x000a0;Patients with more aggressive DLBCL transformation have a 3-year overall survival ranging from 37% to 100%.<xref ref-type="bibr" rid="article-31299.r166">[166]</xref>&#x000a0;Poor prognostic factors include age over 60, elevated serum lactate dehydrogenase level, more than 1 extranodal site, and stage III or IV disease.<xref ref-type="bibr" rid="article-31299.r219">[219]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31299.s16" sec-type="Complications">
        <title>Complications</title>
        <p>The incidence of temporary facial nerve palsy after parotidectomy ranges from 10% to 65%, with permanent paralysis seen in less than 5%.<xref ref-type="bibr" rid="article-31299.r146">[146]</xref><xref ref-type="bibr" rid="article-31299.r220">[220]</xref><xref ref-type="bibr" rid="article-31299.r221">[221]</xref>&#x000a0;The incidence of Frey syndrome after parotidectomy varies widely from 2% to 80% due to the time interval since surgery as well as the surveillance criteria from the surgeons.<xref ref-type="bibr" rid="article-31299.r222">[222]</xref> Treatment for Frey syndrome includes antiperspirant ointment, botulinum toxin A injections, and barrier flaps such as superficial musculoaponeurotic system flap, temporoparietal flap, sternocleidomastoid flap, anterolateral thigh flap, or thick skin flaps.<xref ref-type="bibr" rid="article-31299.r222">[222]</xref><xref ref-type="bibr" rid="article-31299.r223">[223]</xref><xref ref-type="bibr" rid="article-31299.r224">[224]</xref><xref ref-type="bibr" rid="article-31299.r225">[225]</xref>&#x000a0;Additional complications from surgical resection include sialocele, salivary fistula, neuromas of the great auricular nerve, and preauricular skin anesthesia.<xref ref-type="bibr" rid="article-31299.r113">[113]</xref>&#x000a0;Patients who undergo submandibular gland resection or neck dissection for cervical lymph node metastasis have a risk of neurological damage to the spinal accessory, phrenic, hypoglossal, lingual, vagus, sympathetic trunk, and the marginal mandibular branch of the facial nerve.<xref ref-type="bibr" rid="article-31299.r226">[226]</xref><xref ref-type="bibr" rid="article-31299.r227">[227]</xref><xref ref-type="bibr" rid="article-31299.r228">[228]</xref>&#x000a0;Complications from radiation include sensorineural hearing loss, chronic otitis media/externa, otalgia, skin erythema, mucositis, dysphagia, dysgeusia, xerostomia, soft tissue fibrosis, osteoradionecrosis, and radiation-induced malignancy.<xref ref-type="bibr" rid="article-31299.r34">[34]</xref><xref ref-type="bibr" rid="article-31299.r113">[113]</xref>&#x000a0;In a study, approximately 36% of patients were found to develop hearing loss of 10 dB or higher at 4kHz.<xref ref-type="bibr" rid="article-31299.r229">[229]</xref> Mandibular osteoradionecrosis (&#x0003c;2%) and radiation-induced malignancy (1%) at 10 to 25 years are rare complications.<xref ref-type="bibr" rid="article-31299.r113">[113]</xref><xref ref-type="bibr" rid="article-31299.r230">[230]</xref><xref ref-type="bibr" rid="article-31299.r231">[231]</xref><xref ref-type="bibr" rid="article-31299.r232">[232]</xref></p>
      </sec>
      <sec id="article-31299.s17" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Postoperative surveillance aims to detect locoregional recurrence and manage any treatment complications that may arise. Surgery and radiation can result in long-term swallowing difficulties (xerostomia, mucositis, trismus), as well as cosmetic defects from facial nerve paralysis. Early intervention for facial nerve reconstruction and rehabilitation and consultation with speech pathologists for swallowing difficulties is vital for allowing the patient to re-integrate as much as possible into their pre-treatment functional status and improve their quality of life.<xref ref-type="bibr" rid="article-31299.r226">[226]</xref><xref ref-type="bibr" rid="article-31299.r233">[233]</xref><xref ref-type="bibr" rid="article-31299.r234">[234]</xref>&#x000a0;Over 70% of recurrences occur within the first 3 years of treatment, except for low-grade malignancies and AdCC.&#x000a0;According to the National Comprehensive Cancer Network (NCCN) guidelines for post-treatment surveillance, patients should receive regular follow up every 1 to 3 months in the 1 year after treatment, every 2-6 months in the 2 years, every 4-8 months in the 3 to 5 years, and every 12 months after the 5 years.<xref ref-type="bibr" rid="article-31299.r235">[235]</xref> All salivary gland malignancies require post-treatment surveillance for up to 20 years (especially&#x000a0;AdCC due to its propensity for delayed recurrences or metastases). Annual chest imaging should be performed for high-grade lesions and submandibular gland tumors due to the high risk of pulmonary metastasis. Thyroid hormones should be monitored every 6-12 months for neck radiation patients.<xref ref-type="bibr" rid="article-31299.r113">[113]</xref></p>
      </sec>
      <sec id="article-31299.s18" sec-type="Consultations">
        <title>Consultations</title>
        <p>An interprofessional team would need to diagnose and manage salivary malignancies, including an otolaryngologist, general surgeon, plastic or reconstructive surgeon, radiation oncologist, medical oncologist, speech-language pathologist, psychologist, and primary care physician.</p>
      </sec>
      <sec id="article-31299.s19" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be educated on the risk factors for developing salivary gland tumors and counseled to avoid exposure to these risks as much as possible. Patients and their families should be educated on the different treatment options and timelines, including surgical resection, radiation therapy, and chemotherapy. Patients and parents should be counseled on the possible risks and complications of all treatment modalities, and their comorbidities should be fully assessed by their primary care physicians to determine if they are candidates for surgical resection. Long-term follow-up is crucial for salivary malignancies and must be emphasized to patients, given the indolent growth pattern of certain pathologies such as AdCC.</p>
      </sec>
      <sec id="article-31299.s20" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients with salivary malignancies should be managed by a multidisciplinary team of otolaryngologists, plastic surgeons, general surgeons, pathologists, radiation oncologists, medical oncologists, speech-language pathologists, psychologists, and primary care physicians. Salivary malignancies present with varying histologies and severities and often require multimodal therapy involving surgery, radiation, and chemotherapy. Close communication and collaboration between the surgeons, radiation oncologists, and medical oncologists can provide a tailored approach for each patient. Difficulties in swallowing can occur from acute radiation toxicity. Patients may need a consultation with general surgery for gastric tube placement to ensure optimal nutrition perioperatively and for the duration of any adjuvant therapy. The speech-language pathologist's early post-treatment intervention can help patients regain pre-treatment function to prevent malnutrition and dependence on enteral feeding. Recurrence of salivary malignancies can occur several years, even decades, after initial treatment. Thus, the otolaryngologist, medical and radiation oncologists, and primary care physician's routine close follow-up is strongly recommended. Finally, patients may develop visible surgical scarring and facial nerve paralysis associated with depression, social anxiety, and social avoidance. Formal peer support groups and consultation with a psychologist can aid patients in addressing these latter concerns.</p>
      </sec>
      <sec id="article-31299.s21">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31299&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31299">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/malignant-salivary-gland-tumors/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31299">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31299/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31299">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-31299.s22">
        <title>References</title>
        <ref id="article-31299.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boukheris</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Land</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Dores</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>11</issue>
            <fpage>2899</fpage>
            <page-range>2899-906</page-range>
            <pub-id pub-id-type="pmid">19861510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldstein</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Yuen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tucker</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Second cancers after medulloblastoma: population-based results from the United States and Sweden.</article-title>
            <source>Cancer Causes Control</source>
            <year>1997</year>
            <month>Nov</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>865</fpage>
            <page-range>865-71</page-range>
            <pub-id pub-id-type="pmid">9427429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horn-Ross</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Ljung</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Morrow</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Environmental factors and the risk of salivary gland cancer.</article-title>
            <source>Epidemiology</source>
            <year>1997</year>
            <month>Jul</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>414</fpage>
            <page-range>414-9</page-range>
            <pub-id pub-id-type="pmid">9209856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mil&#x000e1;n</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pukkala</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Verkasalo</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Kaprio</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jans&#x000e9;n</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Koskenvuo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Teppo</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.</article-title>
            <source>Int J Cancer</source>
            <year>2000</year>
            <month>Jul</month>
            <day>15</day>
            <volume>87</volume>
            <issue>2</issue>
            <fpage>283</fpage>
            <page-range>283-8</page-range>
            <pub-id pub-id-type="pmid">10861488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fan</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>579</fpage>
            <page-range>579-86</page-range>
            <pub-id pub-id-type="pmid">10757407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nasser</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Faquin</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Dayal</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>119</volume>
            <issue>6</issue>
            <fpage>801</fpage>
            <page-range>801-6</page-range>
            <pub-id pub-id-type="pmid">12817426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwarz-Furlan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brase</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stockmann</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Furlan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Hereditary head and neck tumors].</article-title>
            <source>Pathologe</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>477</fpage>
            <page-range>477-84</page-range>
            <pub-id pub-id-type="pmid">20844882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ettl</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schwarz-Furlan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Haubner</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zenk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gosau</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reichert</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Zeitler</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The PI3K/AKT/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation.</article-title>
            <source>Oral Oncol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>48</volume>
            <issue>9</issue>
            <fpage>822</fpage>
            <page-range>822-30</page-range>
            <pub-id pub-id-type="pmid">22445095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Belsky</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Tachikawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cihak</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland tumors in atomic bomb survivors, Hiroshima-Nagasaki, 1957 to 1970.</article-title>
            <source>JAMA</source>
            <year>1972</year>
            <month>Feb</month>
            <day>14</day>
            <volume>219</volume>
            <issue>7</issue>
            <fpage>864</fpage>
            <page-range>864-8</page-range>
            <pub-id pub-id-type="pmid">5066669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schneider</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Favus</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Stachura</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Frohman</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland neoplasms as a late consequence of head and neck irradiation.</article-title>
            <source>Ann Intern Med</source>
            <year>1977</year>
            <month>Aug</month>
            <volume>87</volume>
            <issue>2</issue>
            <fpage>160</fpage>
            <page-range>160-4</page-range>
            <pub-id pub-id-type="pmid">889197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rice</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Batsakis</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>McClatchey</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Postirradiation malignant salivary gland tumor.</article-title>
            <source>Arch Otolaryngol</source>
            <year>1976</year>
            <month>Nov</month>
            <volume>102</volume>
            <issue>11</issue>
            <fpage>699</fpage>
            <page-range>699-701</page-range>
            <pub-id pub-id-type="pmid">985205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boukheris</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ron</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dores</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Stovall</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis.</article-title>
            <source>Cancer</source>
            <year>2008</year>
            <month>Dec</month>
            <day>01</day>
            <volume>113</volume>
            <issue>11</issue>
            <fpage>3153</fpage>
            <page-range>3153-9</page-range>
            <pub-id pub-id-type="pmid">18823043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayes</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Bravo-Otero</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kleinman</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Fraumeni</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Harty</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Winn</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Tobacco and alcohol use and oral cancer in Puerto Rico.</article-title>
            <source>Cancer Causes Control</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-33</page-range>
            <pub-id pub-id-type="pmid">10334639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sadetzki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oberman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mandelzweig</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chetrit</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ben-Tal</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jarus-Hakak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Duvdevani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cardis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Smoking and risk of parotid gland tumors: a nationwide case-control study.</article-title>
            <source>Cancer</source>
            <year>2008</year>
            <month>May</month>
            <day>01</day>
            <volume>112</volume>
            <issue>9</issue>
            <fpage>1974</fpage>
            <page-range>1974-82</page-range>
            <pub-id pub-id-type="pmid">18361448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Licitra</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Grandi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Prott</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Schornagel</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Bruzzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Molinari</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Major and minor salivary glands tumours.</article-title>
            <source>Crit Rev Oncol Hematol</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>215</fpage>
            <page-range>215-25</page-range>
            <pub-id pub-id-type="pmid">12604131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spitz</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Tilley</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Batsakis</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Gibeau</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Newell</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for major salivary gland carcinoma. A case-comparison study.</article-title>
            <source>Cancer</source>
            <year>1984</year>
            <month>Nov</month>
            <day>01</day>
            <volume>54</volume>
            <issue>9</issue>
            <fpage>1854</fpage>
            <page-range>1854-9</page-range>
            <pub-id pub-id-type="pmid">6478421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muscat</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Wynder</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>A case/control study of risk factors for major salivary gland cancer.</article-title>
            <source>Otolaryngol Head Neck Surg</source>
            <year>1998</year>
            <month>Feb</month>
            <volume>118</volume>
            <issue>2</issue>
            <fpage>195</fpage>
            <page-range>195-8</page-range>
            <pub-id pub-id-type="pmid">9482552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spitz</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Fueger</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Goepfert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Newell</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland cancer. A case-control investigation of risk factors.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>1990</year>
            <month>Oct</month>
            <volume>116</volume>
            <issue>10</issue>
            <fpage>1163</fpage>
            <page-range>1163-6</page-range>
            <pub-id pub-id-type="pmid">2206501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taxy</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Squamous carcinoma in a major salivary gland: a review of the diagnostic considerations.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2001</year>
            <month>Jun</month>
            <volume>125</volume>
            <issue>6</issue>
            <fpage>740</fpage>
            <page-range>740-5</page-range>
            <pub-id pub-id-type="pmid">11371224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shemen</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Huvos</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Spiro</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Squamous cell carcinoma of salivary gland origin.</article-title>
            <source>Head Neck Surg</source>
            <year>1987</year>
            <season>Mar-Apr</season>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>235</fpage>
            <page-range>235-40</page-range>
            <pub-id pub-id-type="pmid">3667298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spitz</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Batsakis</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients.</article-title>
            <source>Arch Otolaryngol</source>
            <year>1984</year>
            <month>Jan</month>
            <volume>110</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-9</page-range>
            <pub-id pub-id-type="pmid">6689907</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Lawson</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Perez-Ordonez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brandwein</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Malignant melanomas of the parotid: comparison of survival for patients with metastases from known vs unknown primary tumor sites.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>125</volume>
            <issue>6</issue>
            <fpage>635</fpage>
            <page-range>635-9</page-range>
            <pub-id pub-id-type="pmid">10367919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>CONLEY</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>ARENA</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>PAROTID GLAND AS A FOCUS OF METASTASIS.</article-title>
            <source>Arch Surg</source>
            <year>1963</year>
            <month>Nov</month>
            <volume>87</volume>
            <fpage>757</fpage>
            <page-range>757-64</page-range>
            <pub-id pub-id-type="pmid">14058839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prayson</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Sebek</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Parotid gland malignant melanomas.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>124</volume>
            <issue>12</issue>
            <fpage>1780</fpage>
            <page-range>1780-4</page-range>
            <pub-id pub-id-type="pmid">11100057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takeda</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Melanocytes in the human parotid gland.</article-title>
            <source>Pathol Int</source>
            <year>1997</year>
            <month>Aug</month>
            <volume>47</volume>
            <issue>8</issue>
            <fpage>581</fpage>
            <page-range>581-3</page-range>
            <pub-id pub-id-type="pmid">9293542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Voulgarelis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dafni</surname>
                <given-names>UG</given-names>
              </name>
              <name>
                <surname>Isenberg</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Moutsopoulos</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Malignant lymphoma in primary Sj&#x000f6;gren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sj&#x000f6;gren's Syndrome.</article-title>
            <source>Arthritis Rheum</source>
            <year>1999</year>
            <month>Aug</month>
            <volume>42</volume>
            <issue>8</issue>
            <fpage>1765</fpage>
            <page-range>1765-72</page-range>
            <pub-id pub-id-type="pmid">10446879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turner</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland disease in Sj&#x000f6;gren's syndrome: sialoadenitis to lymphoma.</article-title>
            <source>Oral Maxillofac Surg Clin North Am</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-81</page-range>
            <pub-id pub-id-type="pmid">24287195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Batsakis</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Regezi</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>The pathology of head and neck tumors: salivary glands, part 1.</article-title>
            <source>Head Neck Surg</source>
            <year>1978</year>
            <season>Sep-Oct</season>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-68</page-range>
            <pub-id pub-id-type="pmid">756396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Speight</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland tumours.</article-title>
            <source>Oral Dis</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>229</fpage>
            <page-range>229-40</page-range>
            <pub-id pub-id-type="pmid">12363107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ettl</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schwarz-Furlan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gosau</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reichert</surname>
                <given-names>TE</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland carcinomas.</article-title>
            <source>Oral Maxillofac Surg</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-83</page-range>
            <pub-id pub-id-type="pmid">22842859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Khateeb</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Ababneh</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <article-title>Salivary tumors in north Jordanians: a descriptive study.</article-title>
            <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
            <year>2007</year>
            <month>May</month>
            <volume>103</volume>
            <issue>5</issue>
            <fpage>e53</fpage>
            <page-range>e53-9</page-range>
            <pub-id pub-id-type="pmid">17368055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Oliveira</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Duarte</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Taveira</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>M&#x000e1;ximo</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>de Aquino</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Alencar</surname>
                <given-names>Rde C</given-names>
              </name>
              <name>
                <surname>Vencio</surname>
                <given-names>EF</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland tumor: a review of 599 cases in a Brazilian population.</article-title>
            <source>Head Neck Pathol</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>3</volume>
            <issue>4</issue>
            <fpage>271</fpage>
            <page-range>271-5</page-range>
            <pub-id pub-id-type="pmid">20596844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Satko</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Stanko</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Longauerov&#x000e1;</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland tumours treated in the stomatological clinics in Bratislava.</article-title>
            <source>J Craniomaxillofac Surg</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>56</fpage>
            <page-range>56-61</page-range>
            <pub-id pub-id-type="pmid">10851675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Slevin</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Mendenhall</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Indications for Salivary Gland Radiotherapy.</article-title>
            <source>Adv Otorhinolaryngol</source>
            <year>2016</year>
            <volume>78</volume>
            <fpage>141</fpage>
            <page-range>141-7</page-range>
            <pub-id pub-id-type="pmid">27093301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spiro</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Management of malignant tumors of the salivary glands.</article-title>
            <source>Oncology (Williston Park)</source>
            <year>1998</year>
            <month>May</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>671</fpage>
            <page-range>671-80; discussion 683</page-range>
            <pub-id pub-id-type="pmid">9597678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bradley</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Frequency and Histopathology by Site, Major Pathologies, Symptoms and Signs of Salivary Gland Neoplasms.</article-title>
            <source>Adv Otorhinolaryngol</source>
            <year>2016</year>
            <volume>78</volume>
            <fpage>9</fpage>
            <page-range>9-16</page-range>
            <pub-id pub-id-type="pmid">27092790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevens</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Andreasen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bj&#x000f8;rndal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hom&#x000f8;e</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Tumors in the parotid are not relatively more often malignant in children than in adults.</article-title>
            <source>Int J Pediatr Otorhinolaryngol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>79</volume>
            <issue>8</issue>
            <fpage>1192</fpage>
            <page-range>1192-5</page-range>
            <pub-id pub-id-type="pmid">25953456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carlson</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>McCoy</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Margins for Benign Salivary Gland Neoplasms of the Head and Neck.</article-title>
            <source>Oral Maxillofac Surg Clin North Am</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>325</fpage>
            <page-range>325-340</page-range>
            <pub-id pub-id-type="pmid">28709532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spiro</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Salivary neoplasms: overview of a 35-year experience with 2,807 patients.</article-title>
            <source>Head Neck Surg</source>
            <year>1986</year>
            <season>Jan-Feb</season>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>177</fpage>
            <page-range>177-84</page-range>
            <pub-id pub-id-type="pmid">3744850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallo</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Franchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bottai</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Fini-Storchi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tesi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Boddi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for distant metastases from carcinoma of the parotid gland.</article-title>
            <source>Cancer</source>
            <year>1997</year>
            <month>Sep</month>
            <day>01</day>
            <volume>80</volume>
            <issue>5</issue>
            <fpage>844</fpage>
            <page-range>844-51</page-range>
            <pub-id pub-id-type="pmid">9307182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ord</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Ghazali</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Margin Analysis: Malignant Salivary Gland Neoplasms of the Head and Neck.</article-title>
            <source>Oral Maxillofac Surg Clin North Am</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>315</fpage>
            <page-range>315-324</page-range>
            <pub-id pub-id-type="pmid">28551337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camilleri</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Malata</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>McLean</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Malignant tumours of the submandibular salivary gland: a 15-year review.</article-title>
            <source>Br J Plast Surg</source>
            <year>1998</year>
            <month>Apr</month>
            <volume>51</volume>
            <issue>3</issue>
            <fpage>181</fpage>
            <page-range>181-5</page-range>
            <pub-id pub-id-type="pmid">9664875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eversole</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Mucoepidermoid carcinoma: review of 815 reported cases.</article-title>
            <source>J Oral Surg</source>
            <year>1970</year>
            <month>Jul</month>
            <volume>28</volume>
            <issue>7</issue>
            <fpage>490</fpage>
            <page-range>490-4</page-range>
            <pub-id pub-id-type="pmid">5269211</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krolls</surname>
                <given-names>SO</given-names>
              </name>
              <name>
                <surname>Trodahl</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Boyers</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland lesions in children. A survey of 430 cases.</article-title>
            <source>Cancer</source>
            <year>1972</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>459</fpage>
            <page-range>459-69</page-range>
            <pub-id pub-id-type="pmid">4340661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;nez-Rodr&#x000ed;guez</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Leco-Berrocal</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rubio-Alonso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Arias-Irimia</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Gonz&#x000e1;lez</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and treatment of adenoid cystic carcinoma of the minor salivary glands: a meta-analytic study.</article-title>
            <source>Med Oral Patol Oral Cir Bucal</source>
            <year>2011</year>
            <month>Nov</month>
            <day>01</day>
            <volume>16</volume>
            <issue>7</issue>
            <fpage>e884</fpage>
            <page-range>e884-9</page-range>
            <pub-id pub-id-type="pmid">21743416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bishop</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Yonescu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Batista</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Eisele</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Westra</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Most nonparotid "acinic cell carcinomas" represent mammary analog secretory carcinomas.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>37</volume>
            <issue>7</issue>
            <fpage>1053</fpage>
            <page-range>1053-7</page-range>
            <pub-id pub-id-type="pmid">23681074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tuffin</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Tyrrell</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Acinic cell carcinoma--Plymouth's experience with postoperative radical radiotherapy.</article-title>
            <source>Br J Oral Maxillofac Surg</source>
            <year>1989</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>186</fpage>
            <page-range>186-91</page-range>
            <pub-id pub-id-type="pmid">2663052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Sebo</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.</article-title>
            <source>Hum Pathol</source>
            <year>2001</year>
            <month>Jun</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>596</fpage>
            <page-range>596-604</page-range>
            <pub-id pub-id-type="pmid">11431714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kimple</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Austin</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Welch</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Funkhouser</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Zanation</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Shockley</surname>
                <given-names>WW</given-names>
              </name>
            </person-group>
            <article-title>Polymorphous low-grade adenocarcinoma: a case series and determination of recurrence.</article-title>
            <source>Laryngoscope</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>124</volume>
            <issue>12</issue>
            <fpage>2714</fpage>
            <page-range>2714-9</page-range>
            <pub-id pub-id-type="pmid">25229805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seethala</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>EN</given-names>
              </name>
            </person-group>
            <article-title>Polymorphous low-grade adenocarcinoma: the University of Pittsburgh experience.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>136</volume>
            <issue>4</issue>
            <fpage>385</fpage>
            <page-range>385-92</page-range>
            <pub-id pub-id-type="pmid">20403856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gilbert</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schmitt</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Ferris</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Duvvuri</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.</article-title>
            <source>JAMA Otolaryngol Head Neck Surg</source>
            <year>2016</year>
            <month>May</month>
            <day>01</day>
            <volume>142</volume>
            <issue>5</issue>
            <fpage>489</fpage>
            <page-range>489-95</page-range>
            <pub-id pub-id-type="pmid">26939990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edafe</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tsirevelou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Goswamy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Understanding primary parotid squamous cell carcinoma - A systematic review.</article-title>
            <source>Surgeon</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>44</fpage>
            <page-range>44-48</page-range>
            <pub-id pub-id-type="pmid">31040083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Borsu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ghossein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Katabi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ganly</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dogan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A proportion of primary squamous cell carcinomas of the parotid gland harbour high-risk human papillomavirus.</article-title>
            <source>Histopathology</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>69</volume>
            <issue>6</issue>
            <fpage>921</fpage>
            <page-range>921-929</page-range>
            <pub-id pub-id-type="pmid">27374168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Batsakis</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>McClatchey</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Johns</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Regazi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Primary squamous cell carcinoma of the parotid gland.</article-title>
            <source>Arch Otolaryngol</source>
            <year>1976</year>
            <month>Jun</month>
            <volume>102</volume>
            <issue>6</issue>
            <fpage>355</fpage>
            <page-range>355-7</page-range>
            <pub-id pub-id-type="pmid">1275803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaughan</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Primary squamous cell carcinoma of the parotid gland.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>1992</year>
            <month>Aug</month>
            <volume>118</volume>
            <issue>8</issue>
            <fpage>798</fpage>
            <page-range>798-801</page-range>
            <pub-id pub-id-type="pmid">1642829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bahar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anavi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ben-Bassat</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Primary malignant melanoma in the parotid gland.</article-title>
            <source>Oral Surg Oral Med Oral Pathol</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>70</volume>
            <issue>5</issue>
            <fpage>627</fpage>
            <page-range>627-30</page-range>
            <pub-id pub-id-type="pmid">2234883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knapper</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Metastatic melanoma of unknown primary.</article-title>
            <source>Cancer</source>
            <year>1982</year>
            <month>Mar</month>
            <day>15</day>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>1106</fpage>
            <page-range>1106-11</page-range>
            <pub-id pub-id-type="pmid">7059936</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klausner</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Gutman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Inbar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rozin</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>Unknown primary melanoma.</article-title>
            <source>J Surg Oncol</source>
            <year>1983</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>129</fpage>
            <page-range>129-31</page-range>
            <pub-id pub-id-type="pmid">6632893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gao</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Primary amelanotic malignant melanoma of the parotid gland: a case report.</article-title>
            <source>J Int Med Res</source>
            <year>2008</year>
            <season>Nov-Dec</season>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>1435</fpage>
            <page-range>1435-9</page-range>
            <pub-id pub-id-type="pmid">19094455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yarington</surname>
                <given-names>CT</given-names>
              </name>
            </person-group>
            <article-title>Metastatic malignant disease to the parotid gland.</article-title>
            <source>Laryngoscope</source>
            <year>1981</year>
            <month>Apr</month>
            <volume>91</volume>
            <issue>4</issue>
            <fpage>517</fpage>
            <page-range>517-9</page-range>
            <pub-id pub-id-type="pmid">6261053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Travaglino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pace</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Varricchio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Picardi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pane</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Staibano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mascolo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Sj&#x000f6;gren Syndrome in Primary Salivary Gland Lymphoma.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2020</year>
            <month>May</month>
            <day>05</day>
            <volume>153</volume>
            <issue>6</issue>
            <fpage>719</fpage>
            <page-range>719-724</page-range>
            <pub-id pub-id-type="pmid">32076706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takahashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsuda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tezuka</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Okabe</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Primary malignant lymphoma of the salivary gland: a tumor of mucosa-associated lymphoid tissue.</article-title>
            <source>J Oral Pathol Med</source>
            <year>1992</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>7</issue>
            <fpage>318</fpage>
            <page-range>318-25</page-range>
            <pub-id pub-id-type="pmid">1522534</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zucca</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Roggero</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bertoni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Conconi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cavalli</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites.</article-title>
            <source>Ann Oncol</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>10</volume>
            <issue>9</issue>
            <fpage>1023</fpage>
            <page-range>1023-33</page-range>
            <pub-id pub-id-type="pmid">10572599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rzepakowska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zwierzy&#x00144;ska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Osuch-W&#x000f3;jcikiewicz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Niemczyk</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Lymphoid tissue neoplasms in the neck region - epidemiological and clinical analysis over 15 years.</article-title>
            <source>Otolaryngol Pol</source>
            <year>2017</year>
            <month>Jun</month>
            <day>30</day>
            <volume>71</volume>
            <issue>3</issue>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">28541247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbondanzo</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Extranodal marginal-zone B-cell lymphoma of the salivary gland.</article-title>
            <source>Ann Diagn Pathol</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>246</fpage>
            <page-range>246-54</page-range>
            <pub-id pub-id-type="pmid">11510008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delli</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vissink</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spijkervet</surname>
                <given-names>FK</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland biopsy for Sj&#x000f6;gren's syndrome.</article-title>
            <source>Oral Maxillofac Surg Clin North Am</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-33</page-range>
            <pub-id pub-id-type="pmid">24287191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kassan</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Moutsopoulos</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Hoover</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kimberly</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Budman</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Decker</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Chused</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Increased risk of lymphoma in sicca syndrome.</article-title>
            <source>Ann Intern Med</source>
            <year>1978</year>
            <month>Dec</month>
            <volume>89</volume>
            <issue>6</issue>
            <fpage>888</fpage>
            <page-range>888-92</page-range>
            <pub-id pub-id-type="pmid">102228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tzioufas</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Boumba</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Skopouli</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Moutsopoulos</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sj&#x000f6;gren's syndrome.</article-title>
            <source>Arthritis Rheum</source>
            <year>1996</year>
            <month>May</month>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>767</fpage>
            <page-range>767-72</page-range>
            <pub-id pub-id-type="pmid">8639173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Neill</surname>
                <given-names>ID</given-names>
              </name>
            </person-group>
            <article-title>t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.</article-title>
            <source>Oral Oncol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-9</page-range>
            <pub-id pub-id-type="pmid">18486532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tonon</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Modi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kubo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Coxon</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Komiya</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>O'Neil</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stover</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>El-Naggar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Kirsch</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>Kaye</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.</article-title>
            <source>Nat Genet</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>208</fpage>
            <page-range>208-13</page-range>
            <pub-id pub-id-type="pmid">12539049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bell</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Dierks</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Homer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Potter</surname>
                <given-names>BE</given-names>
              </name>
            </person-group>
            <article-title>Management and outcome of patients with malignant salivary gland tumors.</article-title>
            <source>J Oral Maxillofac Surg</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>63</volume>
            <issue>7</issue>
            <fpage>917</fpage>
            <page-range>917-28</page-range>
            <pub-id pub-id-type="pmid">16003616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Naggar</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Lovell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Killary</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Clayman</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Batsakis</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>A mucoepidermoid carcinoma of minor salivary gland with t(11;19)(q21;p13.1) as the only karyotypic abnormality.</article-title>
            <source>Cancer Genet Cytogenet</source>
            <year>1996</year>
            <month>Mar</month>
            <volume>87</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-33</page-range>
            <pub-id pub-id-type="pmid">8646736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitani</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lippman</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Caulin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>El-Naggar</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.</article-title>
            <source>Clin Cancer Res</source>
            <year>2010</year>
            <month>Oct</month>
            <day>01</day>
            <volume>16</volume>
            <issue>19</issue>
            <fpage>4722</fpage>
            <page-range>4722-31</page-range>
            <pub-id pub-id-type="pmid">20702610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brill</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Kanner</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Fehr</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Andr&#x000e9;n</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Moskaluk</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>L&#x000f6;ning</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Stenman</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Frierson</surname>
                <given-names>HF</given-names>
              </name>
            </person-group>
            <article-title>Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.</article-title>
            <source>Mod Pathol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>9</issue>
            <fpage>1169</fpage>
            <page-range>1169-76</page-range>
            <pub-id pub-id-type="pmid">21572406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brayer</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Frerich</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ness</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.</article-title>
            <source>Cancer Discov</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>176</fpage>
            <page-range>176-87</page-range>
            <pub-id pub-id-type="pmid">26631070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diegel</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>El-Naggar</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Lindvall</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma.</article-title>
            <source>Cancer Res</source>
            <year>2010</year>
            <month>Nov</month>
            <day>15</day>
            <volume>70</volume>
            <issue>22</issue>
            <fpage>9143</fpage>
            <page-range>9143-52</page-range>
            <pub-id pub-id-type="pmid">21062985</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Locati</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Perrone</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Losa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mela</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Casieri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Orsenigo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cortelazzi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Negri</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tamborini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Quattrone</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bossi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bergamini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Calderone</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Liberatoscioli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Licitra</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs).</article-title>
            <source>Oral Oncol</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>45</volume>
            <issue>11</issue>
            <fpage>986</fpage>
            <page-range>986-90</page-range>
            <pub-id pub-id-type="pmid">19574086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sk&#x000e1;lov&#x000e1;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>St&#x000e1;rek</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Vanecek</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kucerov&#x000e1;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Plank</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sz&#x000e9;pe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Di Palma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leivo</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry.</article-title>
            <source>Histopathology</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>348</fpage>
            <page-range>348-56</page-range>
            <pub-id pub-id-type="pmid">12653946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andreadis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Epivatianos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Poulopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nomikos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Papazoglou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Antoniades</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Barbatis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours.</article-title>
            <source>Oral Oncol</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-65</page-range>
            <pub-id pub-id-type="pmid">16140564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glas</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Hollema</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nap</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Plukker</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.</article-title>
            <source>Cancer</source>
            <year>2002</year>
            <month>Apr</month>
            <day>15</day>
            <volume>94</volume>
            <issue>8</issue>
            <fpage>2211</fpage>
            <page-range>2211-6</page-range>
            <pub-id pub-id-type="pmid">12001119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sugano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mukai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tsuda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hirohashi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Furuya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shimosato</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ebihara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takeyama</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.</article-title>
            <source>Laryngoscope</source>
            <year>1992</year>
            <month>Aug</month>
            <volume>102</volume>
            <issue>8</issue>
            <fpage>923</fpage>
            <page-range>923-7</page-range>
            <pub-id pub-id-type="pmid">1353853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Felix</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>El-Naggar</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Press</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Ordonez</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tucker</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Luna</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Batsakis</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma.</article-title>
            <source>Hum Pathol</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>561</fpage>
            <page-range>561-6</page-range>
            <pub-id pub-id-type="pmid">8666365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Durr</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Mydlarz</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zahurak</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Chuang</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Hoque</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Westra</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Liegeois</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Califano</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sidransky</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Quantitative methylation profiles for multiple tumor suppressor gene promoters in salivary gland tumors.</article-title>
            <source>PLoS One</source>
            <year>2010</year>
            <month>May</month>
            <day>26</day>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>e10828</fpage>
            <pub-id pub-id-type="pmid">20520817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schache</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Woolgar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Nikolaidis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Triantafyllou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Risk</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Liloglou</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma.</article-title>
            <source>Br J Cancer</source>
            <year>2010</year>
            <month>Dec</month>
            <day>07</day>
            <volume>103</volume>
            <issue>12</issue>
            <fpage>1846</fpage>
            <page-range>1846-51</page-range>
            <pub-id pub-id-type="pmid">21063414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Travis</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>McClatchey</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Malignant melanoma of conjunctiva metastatic to parotid gland. Reports of cases and discussion of surgical management.</article-title>
            <source>Laryngoscope</source>
            <year>1977</year>
            <month>Dec</month>
            <volume>87</volume>
            <issue>12</issue>
            <fpage>2000</fpage>
            <page-range>2000-7</page-range>
            <pub-id pub-id-type="pmid">926964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santini</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Melanoma metastatic to cervical and parotid nodes from an unknown primary site.</article-title>
            <source>Am J Surg</source>
            <year>1985</year>
            <month>Oct</month>
            <volume>150</volume>
            <issue>4</issue>
            <fpage>510</fpage>
            <page-range>510-2</page-range>
            <pub-id pub-id-type="pmid">4051118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>GREENE</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>BERNIER</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Primary malignant melanomas of the parotid gland.</article-title>
            <source>Oral Surg Oral Med Oral Pathol</source>
            <year>1961</year>
            <month>Jan</month>
            <volume>14</volume>
            <fpage>108</fpage>
            <page-range>108-16</page-range>
            <pub-id pub-id-type="pmid">13708292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wildenberg</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>van Helden-Meeuwsen</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>van de Merwe</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Drexhage</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Versnel</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Systemic increase in type I interferon activity in Sj&#x000f6;gren's syndrome: a putative role for plasmacytoid dendritic cells.</article-title>
            <source>Eur J Immunol</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>7</issue>
            <fpage>2024</fpage>
            <page-range>2024-33</page-range>
            <pub-id pub-id-type="pmid">18581327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gottenberg</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Cagnard</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lucchesi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Letourneur</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mistou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lazure</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jacques</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ba</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ittah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lepajolec</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Labetoulle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ardizzone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sibilia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fournier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chiocchia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mariette</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sj&#x000f6;gren's syndrome.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2006</year>
            <month>Feb</month>
            <day>21</day>
            <volume>103</volume>
            <issue>8</issue>
            <fpage>2770</fpage>
            <page-range>2770-5</page-range>
            <pub-id pub-id-type="pmid">16477017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mariette</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Lymphomas complicating Sj&#x000f6;gren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>60</volume>
            <issue>11</issue>
            <fpage>1007</fpage>
            <page-range>1007-10</page-range>
            <pub-id pub-id-type="pmid">11602464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jakobsson</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Blanck</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Eneroth</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Mucoepidermoid carcinoma of the parotid gland.</article-title>
            <source>Cancer</source>
            <year>1968</year>
            <month>Jul</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-24</page-range>
            <pub-id pub-id-type="pmid">4298176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Batsakis</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Chinn</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Regezi</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Repola</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>The pathology of head and neck tumors: salivary glands, part 2.</article-title>
            <source>Head Neck Surg</source>
            <year>1978</year>
            <season>Nov-Dec</season>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>167</fpage>
            <page-range>167-80</page-range>
            <pub-id pub-id-type="pmid">755809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>FOOTE</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>FRAZELL</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Tumors of the major salivary glands.</article-title>
            <source>Cancer</source>
            <year>1953</year>
            <month>Nov</month>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>1065</fpage>
            <page-range>1065-133</page-range>
            <pub-id pub-id-type="pmid">13106826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Healey</surname>
                <given-names>WV</given-names>
              </name>
              <name>
                <surname>Perzin</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Mucoepidermoid carcinoma of salivary gland origin. Classification, clinical-pathologic correlation, and results of treatment.</article-title>
            <source>Cancer</source>
            <year>1970</year>
            <month>Aug</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>368</fpage>
            <page-range>368-88</page-range>
            <pub-id pub-id-type="pmid">5451215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yaga</surname>
                <given-names>US</given-names>
              </name>
              <name>
                <surname>Gollamudi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mengji</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Besta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Panta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Prakash</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rajashekar</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Adenoid cystic carcinoma of the palate: case report and review of literature.</article-title>
            <source>Pan Afr Med J</source>
            <year>2016</year>
            <volume>24</volume>
            <fpage>106</fpage>
            <pub-id pub-id-type="pmid">27642445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeAngelis</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Tsui</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wiesenfeld</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chandu</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of patients with adenoid cystic carcinoma of the minor salivary glands.</article-title>
            <source>Int J Oral Maxillofac Surg</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>40</volume>
            <issue>7</issue>
            <fpage>710</fpage>
            <page-range>710-4</page-range>
            <pub-id pub-id-type="pmid">21396798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shimamoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chindasombatjaroen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kakimoto</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kishino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murakami</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Furukawa</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Perineural spread of adenoid cystic carcinoma in the oral and maxillofacial regions: evaluation with contrast-enhanced CT and MRI.</article-title>
            <source>Dentomaxillofac Radiol</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-51</page-range>
            <pub-id pub-id-type="pmid">22301639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>ABRAMS</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>CORNYN</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>SCOFIELD</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>HANSEN</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>ACINIC CELL ADENOCARCINOMA OF THE MAJOR SALIVARY GLANDS. A CLINICOPATHOLOGIC STUDY OF 77 CASES.</article-title>
            <source>Cancer</source>
            <year>1965</year>
            <month>Sep</month>
            <volume>18</volume>
            <fpage>1145</fpage>
            <page-range>1145-62</page-range>
            <pub-id pub-id-type="pmid">14332544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eneroth</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Jakobsson</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Blanck</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Acinic cell carcinoma of the parotid gland.</article-title>
            <source>Cancer</source>
            <year>1966</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>12</issue>
            <fpage>1761</fpage>
            <page-range>1761-72</page-range>
            <pub-id pub-id-type="pmid">5927935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Weiland</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Acinic cell carcinoma. Clinicopathologic review.</article-title>
            <source>Cancer</source>
            <year>1991</year>
            <month>Jan</month>
            <day>01</day>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>172</fpage>
            <page-range>172-9</page-range>
            <pub-id pub-id-type="pmid">1985714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gomez</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Katabi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zhung</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wolden</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Zelefsky</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kraus</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Ghossein</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>NY</given-names>
              </name>
            </person-group>
            <article-title>Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland.</article-title>
            <source>Cancer</source>
            <year>2009</year>
            <month>May</month>
            <day>15</day>
            <volume>115</volume>
            <issue>10</issue>
            <fpage>2128</fpage>
            <page-range>2128-37</page-range>
            <pub-id pub-id-type="pmid">19309749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sk&#x000e1;lov&#x000e1;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sima</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vanecek</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Korabecna</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nemcova</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Elmberger</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Leivo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Passador-Santos</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rousarova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jedlickova</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Curik</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Geierova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Michal</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>33</volume>
            <issue>8</issue>
            <fpage>1137</fpage>
            <page-range>1137-45</page-range>
            <pub-id pub-id-type="pmid">19461506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zengel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>van der Wal</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Guntinas-Lichius</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Schwarz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Kirchner</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ihrler</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases.</article-title>
            <source>Histopathology</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>741</fpage>
            <page-range>741-50</page-range>
            <pub-id pub-id-type="pmid">22014054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwarz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ettl</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Stockmann</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zenk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Agaimy</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.</article-title>
            <source>Int J Clin Exp Pathol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>336</fpage>
            <page-range>336-48</page-range>
            <pub-id pub-id-type="pmid">21577319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darling</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers.</article-title>
            <source>Oral Oncol</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>38</volume>
            <issue>7</issue>
            <fpage>641</fpage>
            <page-range>641-5</page-range>
            <pub-id pub-id-type="pmid">12167416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gibbons</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Saboorian</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Vuitch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gokaslan</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Ashfaq</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Fine-needle aspiration findings in patients with polymorphous low grade adenocarcinoma of the salivary glands.</article-title>
            <source>Cancer</source>
            <year>1999</year>
            <month>Feb</month>
            <day>25</day>
            <volume>87</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-6</page-range>
            <pub-id pub-id-type="pmid">10096357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yener</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Izquierdo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Frank</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>El-Naggar</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Hanna</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Kupferman</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors in adenocarcinoma of the salivary glands.</article-title>
            <source>Oral Oncol</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>6</issue>
            <fpage>610</fpage>
            <page-range>610-5</page-range>
            <pub-id pub-id-type="pmid">25843792</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Escrig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Shaha</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Kraus</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Boyle</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Huvos</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Busam</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Primary mucosal malignant melanoma of the head and neck.</article-title>
            <source>Head Neck</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>247</fpage>
            <page-range>247-57</page-range>
            <pub-id pub-id-type="pmid">11891956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woodwards</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Shepherd</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Hensher</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Malignant melanoma of the parotid gland: a case report and literature review.</article-title>
            <source>Br J Oral Maxillofac Surg</source>
            <year>1993</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>313</fpage>
            <page-range>313-5</page-range>
            <pub-id pub-id-type="pmid">8218087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hwang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
            </person-group>
            <article-title>Mucosa-associated lymphoid tissue lymphoma of the accessory parotid gland presenting as a simple cheek mass: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>98</volume>
            <issue>36</issue>
            <fpage>e17042</fpage>
            <pub-id pub-id-type="pmid">31490395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kroese</surname>
                <given-names>FGM</given-names>
              </name>
              <name>
                <surname>Haacke</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Bombardieri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The role of salivary gland histopathology in primary Sj&#x000f6;gren's syndrome: promises and pitfalls.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2018</year>
            <season>May-Jun</season>
            <volume>36 Suppl 112</volume>
            <issue>3</issue>
            <fpage>222</fpage>
            <page-range>222-233</page-range>
            <pub-id pub-id-type="pmid">30156550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagao</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>"Dedifferentiation" and high-grade transformation in salivary gland carcinomas.</article-title>
            <source>Head Neck Pathol</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>7 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>S37</fpage>
            <page-range>S37-47</page-range>
            <pub-id pub-id-type="pmid">23821210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r113">
          <label>113</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guzzo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Locati</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Prott</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Gatta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McGurk</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Licitra</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Major and minor salivary gland tumors.</article-title>
            <source>Crit Rev Oncol Hematol</source>
            <year>2010</year>
            <month>May</month>
            <volume>74</volume>
            <issue>2</issue>
            <fpage>134</fpage>
            <page-range>134-48</page-range>
            <pub-id pub-id-type="pmid">19939701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r114">
          <label>114</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wierzbicka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kope&#x00107;</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Szyfter</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kereiakes</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bem</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The presence of facial nerve weakness on diagnosis of a parotid gland malignant process.</article-title>
            <source>Eur Arch Otorhinolaryngol</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>269</volume>
            <issue>4</issue>
            <fpage>1177</fpage>
            <page-range>1177-82</page-range>
            <pub-id pub-id-type="pmid">22179671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r115">
          <label>115</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weber</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Petit</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Luna</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Submandibular gland tumors. Adverse histologic factors and therapeutic implications.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>116</volume>
            <issue>9</issue>
            <fpage>1055</fpage>
            <page-range>1055-60</page-range>
            <pub-id pub-id-type="pmid">2166537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r116">
          <label>116</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>The treatment of sublingual gland tumours.</article-title>
            <source>Int J Oral Maxillofac Surg</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>39</volume>
            <issue>9</issue>
            <fpage>863</fpage>
            <page-range>863-8</page-range>
            <pub-id pub-id-type="pmid">20605409</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r117">
          <label>117</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diercks</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Rosow</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kuhel</surname>
                <given-names>WI</given-names>
              </name>
            </person-group>
            <article-title>A case of preoperative "first-bite syndrome" associated with mucoepidermoid carcinoma of the parotid gland.</article-title>
            <source>Laryngoscope</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>121</volume>
            <issue>4</issue>
            <fpage>760</fpage>
            <page-range>760-2</page-range>
            <pub-id pub-id-type="pmid">21344454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r118">
          <label>118</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eneroth</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Zetterberg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A cytochemical method of grading the malignancy of salivary gland tumours preoperatively.</article-title>
            <source>Acta Otolaryngol</source>
            <year>1976</year>
            <season>May-Jun</season>
            <volume>81</volume>
            <issue>5-6</issue>
            <fpage>489</fpage>
            <page-range>489-95</page-range>
            <pub-id pub-id-type="pmid">1274560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r119">
          <label>119</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magaki</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Bhuta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Abemayor</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nabili</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sepahdari</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <article-title>Carcinoma ex-pleomorphic adenoma of the parotid gland consisting of high-grade salivary duct carcinoma and keratinizing squamous cell carcinoma.</article-title>
            <source>Oral Surg Oral Med Oral Pathol Oral Radiol</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>120</volume>
            <issue>3</issue>
            <fpage>e169</fpage>
            <page-range>e169-73</page-range>
            <pub-id pub-id-type="pmid">25782724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r120">
          <label>120</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>K&#x00131;l&#x00131;&#x000e7;kaya</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Aynali</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ceyhan</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>&#x000c7;iri&#x0015f;</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Metastatic Malignant Melanoma of Parotid Gland with a Regressed Primary Tumor.</article-title>
            <source>Case Rep Otolaryngol</source>
            <year>2016</year>
            <volume>2016</volume>
            <fpage>5393404</fpage>
            <pub-id pub-id-type="pmid">27478668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r121">
          <label>121</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Ahuja</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Imaging of salivary gland tumours.</article-title>
            <source>Eur J Radiol</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>66</volume>
            <issue>3</issue>
            <fpage>419</fpage>
            <page-range>419-36</page-range>
            <pub-id pub-id-type="pmid">18337041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r122">
          <label>122</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kovacevi&#x00107;</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Fabijani&#x00107;</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Sonographic diagnosis of parotid gland lesions: correlation with the results of sonographically guided fine-needle aspiration biopsy.</article-title>
            <source>J Clin Ultrasound</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>294</fpage>
            <page-range>294-8</page-range>
            <pub-id pub-id-type="pmid">20544864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r123">
          <label>123</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanna</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vural</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Prokopakis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Carrau</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Snyderman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Weissman</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The sensitivity and specificity of high-resolution imaging in evaluating perineural spread of adenoid cystic carcinoma to the skull base.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>133</volume>
            <issue>6</issue>
            <fpage>541</fpage>
            <page-range>541-5</page-range>
            <pub-id pub-id-type="pmid">17576903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r124">
          <label>124</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burke</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Howlett</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Imaging the major salivary glands.</article-title>
            <source>Br J Oral Maxillofac Surg</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>261</fpage>
            <page-range>261-9</page-range>
            <pub-id pub-id-type="pmid">20381221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r125">
          <label>125</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wittekindt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Burmeister</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Guntinas-Lichius</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>[Diagnostic and therapy of salivary gland diseases: relevant aspects for the pathologist from the clinical perspective].</article-title>
            <source>Pathologe</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>424</fpage>
            <page-range>424-31</page-range>
            <pub-id pub-id-type="pmid">19756611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r126">
          <label>126</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Habermann</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Arndt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Graessner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Diestel</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>KU</given-names>
              </name>
              <name>
                <surname>Reitmeier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ussmueller</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Adam</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jaehne</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?</article-title>
            <source>AJNR Am J Neuroradiol</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>591</fpage>
            <page-range>591-6</page-range>
            <pub-id pub-id-type="pmid">19131405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r127">
          <label>127</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roh</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Nam</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SY</given-names>
              </name>
            </person-group>
            <article-title>Clinical utility of 18F-FDG PET for patients with salivary gland malignancies.</article-title>
            <source>J Nucl Med</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>240</fpage>
            <page-range>240-6</page-range>
            <pub-id pub-id-type="pmid">17268021</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r128">
          <label>128</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeong</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Son</surname>
                <given-names>YI</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Role of 18F-FDG PET/CT in management of high-grade salivary gland malignancies.</article-title>
            <source>J Nucl Med</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>48</volume>
            <issue>8</issue>
            <fpage>1237</fpage>
            <page-range>1237-44</page-range>
            <pub-id pub-id-type="pmid">17631549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r129">
          <label>129</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uchida</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Minoshima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kawata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Motoori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nakano</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kazama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Uno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okamoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors.</article-title>
            <source>Clin Nucl Med</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>170</fpage>
            <page-range>170-6</page-range>
            <pub-id pub-id-type="pmid">15722820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r130">
          <label>130</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keyes</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Harkness</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Greven</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>McGuirt</surname>
                <given-names>WF</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland tumors: pretherapy evaluation with PET.</article-title>
            <source>Radiology</source>
            <year>1994</year>
            <month>Jul</month>
            <volume>192</volume>
            <issue>1</issue>
            <fpage>99</fpage>
            <page-range>99-102</page-range>
            <pub-id pub-id-type="pmid">8208973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r131">
          <label>131</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kechagias</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ntomouchtsis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Valeri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Patrikidou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kitikidou</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Xirou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Destouni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vahtsevanos</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Antoniades</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Fine-needle aspiration cytology of salivary gland tumours: a 10-year retrospective analysis.</article-title>
            <source>Oral Maxillofac Surg</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-40</page-range>
            <pub-id pub-id-type="pmid">21894513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r132">
          <label>132</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Layfield</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>A systematic review and meta-analysis of the diagnostic accuracy of fine-needle aspiration cytology for parotid gland lesions.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>136</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-59</page-range>
            <pub-id pub-id-type="pmid">21685031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r133">
          <label>133</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colella</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cannavale</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Flamminio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Foschini</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Fine-needle aspiration cytology of salivary gland lesions: a systematic review.</article-title>
            <source>J Oral Maxillofac Surg</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>68</volume>
            <issue>9</issue>
            <fpage>2146</fpage>
            <page-range>2146-53</page-range>
            <pub-id pub-id-type="pmid">20580145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r134">
          <label>134</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Routsias</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Goules</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Charalampakis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tzima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Papageorgiou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Voulgarelis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Malignant lymphoma in primary Sj&#x000f6;gren's syndrome: an update on the pathogenesis and treatment.</article-title>
            <source>Semin Arthritis Rheum</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>178</fpage>
            <page-range>178-86</page-range>
            <pub-id pub-id-type="pmid">23816048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r135">
          <label>135</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Layfield</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>A systematic review and meta-analysis of the diagnostic accuracy of ultrasound-guided core needle biopsy for salivary gland lesions.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>136</volume>
            <issue>4</issue>
            <fpage>516</fpage>
            <page-range>516-26</page-range>
            <pub-id pub-id-type="pmid">21917673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r136">
          <label>136</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Layfield</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>A systematic review and meta-analysis of the diagnostic accuracy of frozen section for parotid gland lesions.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>136</volume>
            <issue>5</issue>
            <fpage>729</fpage>
            <page-range>729-38</page-range>
            <pub-id pub-id-type="pmid">22031311</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r137">
          <label>137</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fu</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Leibel</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Friedlander</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Boles</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures.</article-title>
            <source>Cancer</source>
            <year>1977</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>2882</fpage>
            <page-range>2882-90</page-range>
            <pub-id pub-id-type="pmid">201357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r138">
          <label>138</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Armstrong</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Spiro</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Fass</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Strong</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Fuks</surname>
                <given-names>ZY</given-names>
              </name>
            </person-group>
            <article-title>Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>116</volume>
            <issue>3</issue>
            <fpage>290</fpage>
            <page-range>290-3</page-range>
            <pub-id pub-id-type="pmid">2306346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r139">
          <label>139</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terhaard</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lubsen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rasch</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Levendag</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Kaanders</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Tjho-Heslinga</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>van Den Ende</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Burlage</surname>
                <given-names>F</given-names>
              </name>
              <collab>Dutch Head and Neck Oncology Cooperative Group</collab>
            </person-group>
            <article-title>The role of radiotherapy in the treatment of malignant salivary gland tumors.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2005</year>
            <month>Jan</month>
            <day>01</day>
            <volume>61</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-11</page-range>
            <pub-id pub-id-type="pmid">15629600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r140">
          <label>140</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Maghami</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Management of Malignant Salivary Gland Tumors of the Parotid Gland.</article-title>
            <source>Otolaryngol Clin North Am</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>49</volume>
            <issue>2</issue>
            <fpage>343</fpage>
            <page-range>343-80</page-range>
            <pub-id pub-id-type="pmid">27040585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r141">
          <label>141</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Limesand</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Ann</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Current State of Knowledge on Salivary Gland Cancers.</article-title>
            <source>Crit Rev Oncog</source>
            <year>2018</year>
            <volume>23</volume>
            <issue>3-4</issue>
            <fpage>139</fpage>
            <page-range>139-151</page-range>
            <pub-id pub-id-type="pmid">30311570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r142">
          <label>142</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terhaard</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Postoperative and primary radiotherapy for salivary gland carcinomas: indications, techniques, and results.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2007</year>
            <volume>69</volume>
            <issue>2 Suppl</issue>
            <fpage>S52</fpage>
            <page-range>S52-5</page-range>
            <pub-id pub-id-type="pmid">17848295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r143">
          <label>143</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendenhall</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Amdur</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Werning</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Villaret</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Radiotherapy alone or combined with surgery for salivary gland carcinoma.</article-title>
            <source>Cancer</source>
            <year>2005</year>
            <month>Jun</month>
            <day>15</day>
            <volume>103</volume>
            <issue>12</issue>
            <fpage>2544</fpage>
            <page-range>2544-50</page-range>
            <pub-id pub-id-type="pmid">15880750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r144">
          <label>144</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spiro</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Spiro</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Cancer of the parotid gland: role of 7th nerve preservation.</article-title>
            <source>World J Surg</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>7</issue>
            <fpage>863</fpage>
            <page-range>863-7</page-range>
            <pub-id pub-id-type="pmid">14509520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r145">
          <label>145</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harish</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Management of primary malignant epithelial parotid tumors.</article-title>
            <source>Surg Oncol</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-16</page-range>
            <pub-id pub-id-type="pmid">15145029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r146">
          <label>146</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Koo</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>EC</given-names>
              </name>
            </person-group>
            <article-title>Conservative parotidectomy for the treatment of parotid cancers.</article-title>
            <source>Oral Oncol</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>41</volume>
            <issue>10</issue>
            <fpage>1021</fpage>
            <page-range>1021-7</page-range>
            <pub-id pub-id-type="pmid">16129655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r147">
          <label>147</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Domenick</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Parotid tumor size predicts proximity to the facial nerve.</article-title>
            <source>Laryngoscope</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>121</volume>
            <issue>11</issue>
            <fpage>2366</fpage>
            <page-range>2366-70</page-range>
            <pub-id pub-id-type="pmid">22020887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r148">
          <label>148</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roh</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>CI</given-names>
              </name>
            </person-group>
            <article-title>Randomized clinical trial comparing partial parotidectomy versus superficial or total parotidectomy.</article-title>
            <source>Br J Surg</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>94</volume>
            <issue>9</issue>
            <fpage>1081</fpage>
            <page-range>1081-7</page-range>
            <pub-id pub-id-type="pmid">17701949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r149">
          <label>149</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salama</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Ord</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Clinical implications of the neck in salivary gland disease.</article-title>
            <source>Oral Maxillofac Surg Clin North Am</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>445</fpage>
            <page-range>445-58</page-range>
            <pub-id pub-id-type="pmid">18603202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r150">
          <label>150</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spiro</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Geller</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Strong</surname>
                <given-names>EW</given-names>
              </name>
            </person-group>
            <article-title>Carcinoma of major salivary glands. Recent trends.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>1989</year>
            <month>Mar</month>
            <volume>115</volume>
            <issue>3</issue>
            <fpage>316</fpage>
            <page-range>316-21</page-range>
            <pub-id pub-id-type="pmid">2537093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r151">
          <label>151</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Armstrong</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Thaler</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Friedlander-Klar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fass</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Zelefsky</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Strong</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Spiro</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>The indications for elective treatment of the neck in cancer of the major salivary glands.</article-title>
            <source>Cancer</source>
            <year>1992</year>
            <month>Feb</month>
            <day>01</day>
            <volume>69</volume>
            <issue>3</issue>
            <fpage>615</fpage>
            <page-range>615-9</page-range>
            <pub-id pub-id-type="pmid">1730113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r152">
          <label>152</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez-Cuevas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Labastida</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baena</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gallegos</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Risk of nodal metastases from malignant salivary gland tumors related to tumor size and grade of malignancy.</article-title>
            <source>Eur Arch Otorhinolaryngol</source>
            <year>1995</year>
            <volume>252</volume>
            <issue>3</issue>
            <fpage>139</fpage>
            <page-range>139-42</page-range>
            <pub-id pub-id-type="pmid">7662346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r153">
          <label>153</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lloyd</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Decker</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>A prognostic index for predicting lymph node metastasis in minor salivary gland cancer.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2010</year>
            <month>Jan</month>
            <day>01</day>
            <volume>76</volume>
            <issue>1</issue>
            <fpage>169</fpage>
            <page-range>169-75</page-range>
            <pub-id pub-id-type="pmid">19386433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r154">
          <label>154</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schramm</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Imola</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Management of nasopharyngeal salivary gland malignancy.</article-title>
            <source>Laryngoscope</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>111</volume>
            <issue>9</issue>
            <fpage>1533</fpage>
            <page-range>1533-44</page-range>
            <pub-id pub-id-type="pmid">11568602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r155">
          <label>155</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ettl</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schwarz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kleinsasser</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reichert</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Driemel</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.</article-title>
            <source>Histopathology</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>53</volume>
            <issue>5</issue>
            <fpage>567</fpage>
            <page-range>567-77</page-range>
            <pub-id pub-id-type="pmid">18983466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r156">
          <label>156</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jaehne</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roeser</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jaekel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schepers</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>L&#x000f6;ning</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.</article-title>
            <source>Cancer</source>
            <year>2005</year>
            <month>Jun</month>
            <day>15</day>
            <volume>103</volume>
            <issue>12</issue>
            <fpage>2526</fpage>
            <page-range>2526-33</page-range>
            <pub-id pub-id-type="pmid">15900577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r157">
          <label>157</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stennert</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kisner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jungehuelsing</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guntinas-Lichius</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Schr&#x000f6;der</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Eckel</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Klussmann</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>High incidence of lymph node metastasis in major salivary gland cancer.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>129</volume>
            <issue>7</issue>
            <fpage>720</fpage>
            <page-range>720-3</page-range>
            <pub-id pub-id-type="pmid">12874071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r158">
          <label>158</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frankenthaler</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Luna</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Callender</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Goepfert</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Predicting occult lymph node metastasis in parotid cancer.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>1993</year>
            <month>May</month>
            <volume>119</volume>
            <issue>5</issue>
            <fpage>517</fpage>
            <page-range>517-20</page-range>
            <pub-id pub-id-type="pmid">8484940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r159">
          <label>159</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chisholm</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Elmiyeh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dwivedi</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thway</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kerawala</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Clarke</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Rhys-Evans</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Anatomic distribution of cervical lymph node spread in parotid carcinoma.</article-title>
            <source>Head Neck</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>513</fpage>
            <page-range>513-5</page-range>
            <pub-id pub-id-type="pmid">20652975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r160">
          <label>160</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferlito</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shaha</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Rinaldo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mondin</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Management of clinically negative cervical lymph nodes in patients with malignant neoplasms of the parotid gland.</article-title>
            <source>ORL J Otorhinolaryngol Relat Spec</source>
            <year>2001</year>
            <season>May-Jun</season>
            <volume>63</volume>
            <issue>3</issue>
            <fpage>123</fpage>
            <page-range>123-6</page-range>
            <pub-id pub-id-type="pmid">11359087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r161">
          <label>161</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Medina</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Neck dissection in the treatment of cancer of major salivary glands.</article-title>
            <source>Otolaryngol Clin North Am</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>815</fpage>
            <page-range>815-22</page-range>
            <pub-id pub-id-type="pmid">9735109</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r162">
          <label>162</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ziglinas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zb&#x000e4;ren</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Primary tumors of the submandibular glands: a retrospective study based on 41 cases.</article-title>
            <source>Oral Oncol</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>287</fpage>
            <page-range>287-91</page-range>
            <pub-id pub-id-type="pmid">20189445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r163">
          <label>163</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salgado</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Spratt</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Riaz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Romesser</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Wolden</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>NY</given-names>
              </name>
            </person-group>
            <article-title>Radiation therapy in the treatment of minor salivary gland tumors.</article-title>
            <source>Am J Clin Oncol</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>37</volume>
            <issue>5</issue>
            <fpage>492</fpage>
            <page-range>492-7</page-range>
            <pub-id pub-id-type="pmid">23428950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r164">
          <label>164</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garden</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>el-Naggar</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Callender</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Ang</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Postoperative radiotherapy for malignant tumors of the parotid gland.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>1997</year>
            <month>Jan</month>
            <day>01</day>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>79</fpage>
            <page-range>79-85</page-range>
            <pub-id pub-id-type="pmid">9054880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r165">
          <label>165</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laramore</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Krall</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Duncan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Saroja</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Maor</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>LW</given-names>
              </name>
            </person-group>
            <article-title>Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>1993</year>
            <month>Sep</month>
            <day>30</day>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>235</fpage>
            <page-range>235-40</page-range>
            <pub-id pub-id-type="pmid">8407397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r166">
          <label>166</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Voulgarelis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ziakas</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Papageorgiou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baimpa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tzioufas</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Moutsopoulos</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Prognosis and outcome of non-Hodgkin lymphoma in primary Sj&#x000f6;gren syndrome.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>91</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">22198497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r167">
          <label>167</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schoenfeld</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Sher</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Norris</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Haddad</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Posner</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Balboni</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Tishler</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2012</year>
            <month>Jan</month>
            <day>01</day>
            <volume>82</volume>
            <issue>1</issue>
            <fpage>308</fpage>
            <page-range>308-14</page-range>
            <pub-id pub-id-type="pmid">21075557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r168">
          <label>168</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Pajak</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Forastiere</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Saxman</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Kish</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Cmelak</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Rotman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Machtay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ensley</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Chao</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Schultz</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>KK</given-names>
              </name>
              <collab>Radiation Therapy Oncology Group 9501/Intergroup</collab>
            </person-group>
            <article-title>Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>May</month>
            <day>06</day>
            <volume>350</volume>
            <issue>19</issue>
            <fpage>1937</fpage>
            <page-range>1937-44</page-range>
            <pub-id pub-id-type="pmid">15128893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r169">
          <label>169</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pederson</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Salama</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Haraf</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Witt</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Stenson</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Portugal</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Seiwert</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Villaflor</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Vokes</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Blair</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.</article-title>
            <source>Head Neck Oncol</source>
            <year>2011</year>
            <month>Jul</month>
            <day>26</day>
            <volume>3</volume>
            <fpage>31</fpage>
            <pub-id pub-id-type="pmid">21791072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r170">
          <label>170</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cerda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>XS</given-names>
              </name>
              <name>
                <surname>Vignot</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marcy</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Baujat</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Baglin</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Testelin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reyt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Janot</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Thariat</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network).</article-title>
            <source>Crit Rev Oncol Hematol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>91</volume>
            <issue>2</issue>
            <fpage>142</fpage>
            <page-range>142-58</page-range>
            <pub-id pub-id-type="pmid">24636481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r171">
          <label>171</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakano</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shimbashi</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Fukushima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yonekawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mitani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kawabata</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Combination chemotherapy of carboplatin and paclitaxel for advanced/metastatic salivary gland carcinoma patients: differences in responses by different pathological diagnoses.</article-title>
            <source>Acta Otolaryngol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>136</volume>
            <issue>9</issue>
            <fpage>948</fpage>
            <page-range>948-51</page-range>
            <pub-id pub-id-type="pmid">27094013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r172">
          <label>172</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papaspyrou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hoch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rinaldo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rodrigo</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Takes</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>van Herpen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Werner</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ferlito</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review.</article-title>
            <source>Head Neck</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>905</fpage>
            <page-range>905-11</page-range>
            <pub-id pub-id-type="pmid">20652885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r173">
          <label>173</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laurie</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Siu</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Winquist</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Maksymiuk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harnett</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Tu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Parulekar</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials Group.</article-title>
            <source>Cancer</source>
            <year>2010</year>
            <month>Jan</month>
            <day>15</day>
            <volume>116</volume>
            <issue>2</issue>
            <fpage>362</fpage>
            <page-range>362-8</page-range>
            <pub-id pub-id-type="pmid">19924794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r174">
          <label>174</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Kies</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>El-Naggar</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.</article-title>
            <source>Clin Cancer Res</source>
            <year>2010</year>
            <month>Apr</month>
            <day>15</day>
            <volume>16</volume>
            <issue>8</issue>
            <fpage>2266</fpage>
            <page-range>2266-74</page-range>
            <pub-id pub-id-type="pmid">20371674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r175">
          <label>175</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holst</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Moskaluk</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Frierson</surname>
                <given-names>HF</given-names>
              </name>
            </person-group>
            <article-title>KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.</article-title>
            <source>Mod Pathol</source>
            <year>1999</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>10</issue>
            <fpage>956</fpage>
            <page-range>956-60</page-range>
            <pub-id pub-id-type="pmid">10530560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r176">
          <label>176</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frattini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saletti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Romagnani</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Molinari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ghisletta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Camponovo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Etienne</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Cavalli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mazzucchelli</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients.</article-title>
            <source>Br J Cancer</source>
            <year>2007</year>
            <month>Oct</month>
            <day>22</day>
            <volume>97</volume>
            <issue>8</issue>
            <fpage>1139</fpage>
            <page-range>1139-45</page-range>
            <pub-id pub-id-type="pmid">17940504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r177">
          <label>177</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haddad</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Colevas</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Krane</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Glisson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Amrein</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Weeks</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Costello</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Posner</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study.</article-title>
            <source>Oral Oncol</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>724</fpage>
            <page-range>724-7</page-range>
            <pub-id pub-id-type="pmid">12907212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r178">
          <label>178</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vidal</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tsao</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Pond</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>EX</given-names>
              </name>
              <name>
                <surname>Agulnik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hotte</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Winquist</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Laurie</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dancey</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Siu</surname>
                <given-names>LL</given-names>
              </name>
            </person-group>
            <article-title>Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib.</article-title>
            <source>Head Neck</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>31</volume>
            <issue>8</issue>
            <fpage>1006</fpage>
            <page-range>1006-12</page-range>
            <pub-id pub-id-type="pmid">19309723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r179">
          <label>179</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ciardiello</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tortora</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>EGFR antagonists in cancer treatment.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>Mar</month>
            <day>13</day>
            <volume>358</volume>
            <issue>11</issue>
            <fpage>1160</fpage>
            <page-range>1160-74</page-range>
            <pub-id pub-id-type="pmid">18337605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r180">
          <label>180</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edge</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Compton</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>6</issue>
            <fpage>1471</fpage>
            <page-range>1471-4</page-range>
            <pub-id pub-id-type="pmid">20180029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r181">
          <label>181</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lydiatt</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brandwein</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Ridge</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Migliacci</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Loomis</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.</article-title>
            <source>CA Cancer J Clin</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>122</fpage>
            <page-range>122-137</page-range>
            <pub-id pub-id-type="pmid">28128848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r182">
          <label>182</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheson</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Barrington</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Cavalli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Zucca</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lister</surname>
                <given-names>TA</given-names>
              </name>
              <collab>Alliance, Australasian Leukaemia and Lymphoma Group</collab>
              <collab>Eastern Cooperative Oncology Group</collab>
              <collab>European Mantle Cell Lymphoma Consortium</collab>
              <collab>Italian Lymphoma Foundation</collab>
              <collab>European Organisation for Research</collab>
              <collab>Treatment of Cancer/Dutch Hemato-Oncology Group</collab>
              <collab>Grupo Espa&#x000f1;ol de M&#x000e9;dula &#x000d3;sea</collab>
              <collab>German High-Grade Lymphoma Study Group</collab>
              <collab>German Hodgkin's Study Group</collab>
              <collab>Japanese Lymphorra Study Group</collab>
              <collab>Lymphoma Study Association</collab>
              <collab>NCIC Clinical Trials Group</collab>
              <collab>Nordic Lymphoma Study Group</collab>
              <collab>Southwest Oncology Group</collab>
              <collab>United Kingdom National Cancer Research Institute</collab>
            </person-group>
            <article-title>Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.</article-title>
            <source>J Clin Oncol</source>
            <year>2014</year>
            <month>Sep</month>
            <day>20</day>
            <volume>32</volume>
            <issue>27</issue>
            <fpage>3059</fpage>
            <page-range>3059-68</page-range>
            <pub-id pub-id-type="pmid">25113753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r183">
          <label>183</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sultan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rodriguez-Galindo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Al-Sharabati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guzzo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Casanova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland carcinomas in children and adolescents: a population-based study, with comparison to adult cases.</article-title>
            <source>Head Neck</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>33</volume>
            <issue>10</issue>
            <fpage>1476</fpage>
            <page-range>1476-81</page-range>
            <pub-id pub-id-type="pmid">21928420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r184">
          <label>184</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kupferman</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>de la Garza</surname>
                <given-names>GO</given-names>
              </name>
              <name>
                <surname>Santillan</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Varghese</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Huh</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of pediatric patients with malignancies of the major salivary glands.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>17</volume>
            <issue>12</issue>
            <fpage>3301</fpage>
            <page-range>3301-7</page-range>
            <pub-id pub-id-type="pmid">20585877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r185">
          <label>185</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Renehan</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Gleave</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Slevin</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>McGurk</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinico-pathological and treatment-related factors influencing survival in parotid cancer.</article-title>
            <source>Br J Cancer</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>80</volume>
            <issue>8</issue>
            <fpage>1296</fpage>
            <page-range>1296-300</page-range>
            <pub-id pub-id-type="pmid">10376987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r186">
          <label>186</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Therkildsen</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Schi&#x000f8;dt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland carcinomas--prognostic factors.</article-title>
            <source>Acta Oncol</source>
            <year>1998</year>
            <volume>37</volume>
            <issue>7-8</issue>
            <fpage>701</fpage>
            <page-range>701-13</page-range>
            <pub-id pub-id-type="pmid">10050991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r187">
          <label>187</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwarz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stiegler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ettl</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Brockhoff</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zenk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Agaimy</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Salivary gland mucoepidermoid carcinoma is a clinically, morphologically and genetically heterogeneous entity: a clinicopathological study of 40 cases with emphasis on grading, histological variants and presence of the t(11;19) translocation.</article-title>
            <source>Histopathology</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>58</volume>
            <issue>4</issue>
            <fpage>557</fpage>
            <page-range>557-70</page-range>
            <pub-id pub-id-type="pmid">21371076</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r188">
          <label>188</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhattacharyya</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fried</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Determinants of survival in parotid gland carcinoma: a population-based study.</article-title>
            <source>Am J Otolaryngol</source>
            <year>2005</year>
            <season>Jan-Feb</season>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-44</page-range>
            <pub-id pub-id-type="pmid">15635580</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r189">
          <label>189</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Speight</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors in malignant tumours of the salivary glands.</article-title>
            <source>Br J Oral Maxillofac Surg</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>47</volume>
            <issue>8</issue>
            <fpage>587</fpage>
            <page-range>587-93</page-range>
            <pub-id pub-id-type="pmid">19409681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r190">
          <label>190</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hocwald</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Korkmaz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Adsay</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Shibuya</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors in major salivary gland cancer.</article-title>
            <source>Laryngoscope</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>111</volume>
            <issue>8</issue>
            <fpage>1434</fpage>
            <page-range>1434-9</page-range>
            <pub-id pub-id-type="pmid">11568581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r191">
          <label>191</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelley</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Spiro</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Management of the neck in parotid carcinoma.</article-title>
            <source>Am J Surg</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>172</volume>
            <issue>6</issue>
            <fpage>695</fpage>
            <page-range>695-7</page-range>
            <pub-id pub-id-type="pmid">8988681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r192">
          <label>192</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliveira</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Soave</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Oliveira-Costa</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Zorgetto</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Ribeiro-Silva</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors in patients with malignant salivary gland neoplasms in a Brazilian population.</article-title>
            <source>Asian Pac J Cancer Prev</source>
            <year>2011</year>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>363</fpage>
            <page-range>363-8</page-range>
            <pub-id pub-id-type="pmid">21545195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r193">
          <label>193</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dahlem</surname>
                <given-names>KKK</given-names>
              </name>
              <name>
                <surname>Pfeiffer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Prognostic value of comorbidities in patients with carcinoma of the major salivary glands.</article-title>
            <source>Eur Arch Otorhinolaryngol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>274</volume>
            <issue>3</issue>
            <fpage>1651</fpage>
            <page-range>1651-1657</page-range>
            <pub-id pub-id-type="pmid">27888340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r194">
          <label>194</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glazer</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Shuman</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Distant Metastases and Palliative Care.</article-title>
            <source>Adv Otorhinolaryngol</source>
            <year>2016</year>
            <volume>78</volume>
            <fpage>182</fpage>
            <page-range>182-8</page-range>
            <pub-id pub-id-type="pmid">27092552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r195">
          <label>195</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thorvaldsson</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Beahrs</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Woolner</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Simons</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Mucoepidermoid tumors of the major salivary glands.</article-title>
            <source>Am J Surg</source>
            <year>1970</year>
            <month>Oct</month>
            <volume>120</volume>
            <issue>4</issue>
            <fpage>432</fpage>
            <page-range>432-8</page-range>
            <pub-id pub-id-type="pmid">5507327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r196">
          <label>196</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brandwein</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Ivanov</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Hille</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fahmy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bodian</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Urken</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Gnepp</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Huvos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lumerman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mills</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>25</volume>
            <issue>7</issue>
            <fpage>835</fpage>
            <page-range>835-45</page-range>
            <pub-id pub-id-type="pmid">11420454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r197">
          <label>197</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guzzo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andreola</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sirizzotti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cantu</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>9</volume>
            <issue>7</issue>
            <fpage>688</fpage>
            <page-range>688-95</page-range>
            <pub-id pub-id-type="pmid">12167584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r198">
          <label>198</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clode</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Soares</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Mucoepidermoid carcinoma of the salivary glands: a reappraisal of the influence of tumor differentiation on prognosis.</article-title>
            <source>J Surg Oncol</source>
            <year>1991</year>
            <month>Feb</month>
            <volume>46</volume>
            <issue>2</issue>
            <fpage>100</fpage>
            <page-range>100-6</page-range>
            <pub-id pub-id-type="pmid">1992215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r199">
          <label>199</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Witt</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Major salivary gland cancer.</article-title>
            <source>Surg Oncol Clin N Am</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>113</fpage>
            <page-range>113-27</page-range>
            <pub-id pub-id-type="pmid">15062365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r200">
          <label>200</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rinaldo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferlito</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pellitteri</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Robbins</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Shaha</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Kowalski</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>WI</given-names>
              </name>
            </person-group>
            <article-title>Management of malignant submandibular gland tumors.</article-title>
            <source>Acta Otolaryngol</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>123</volume>
            <issue>8</issue>
            <fpage>896</fpage>
            <page-range>896-904</page-range>
            <pub-id pub-id-type="pmid">14606589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r201">
          <label>201</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cohen</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Damrose</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>RY</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Blackwell</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Calcaterra</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Adenoid cystic carcinoma of the submandibular gland: a 35-year review.</article-title>
            <source>Otolaryngol Head Neck Surg</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>131</volume>
            <issue>6</issue>
            <fpage>994</fpage>
            <page-range>994-1000</page-range>
            <pub-id pub-id-type="pmid">15577803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r202">
          <label>202</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamper</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lazar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dietel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Caselitz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Arps</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Falkmer</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Auer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Seifert</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors for adenoid cystic carcinoma of the head and neck: a retrospective evaluation of 96 cases.</article-title>
            <source>J Oral Pathol Med</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>101</fpage>
            <page-range>101-7</page-range>
            <pub-id pub-id-type="pmid">2160530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r203">
          <label>203</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perzin</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Gullane</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Clairmont</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course.</article-title>
            <source>Cancer</source>
            <year>1978</year>
            <month>Jul</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>265</fpage>
            <page-range>265-82</page-range>
            <pub-id pub-id-type="pmid">208752</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r204">
          <label>204</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neskey</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Hicks</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garden</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>El-Naggar</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Kies</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Kupferman</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors associated with decreased survival in patients with acinic cell carcinoma.</article-title>
            <source>JAMA Otolaryngol Head Neck Surg</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>139</volume>
            <issue>11</issue>
            <fpage>1195</fpage>
            <page-range>1195-202</page-range>
            <pub-id pub-id-type="pmid">24076756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r205">
          <label>205</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chong</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Beahrs</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Woolner</surname>
                <given-names>LB</given-names>
              </name>
            </person-group>
            <article-title>Surgical management of acinic cell carcinoma of the parotid gland.</article-title>
            <source>Surg Gynecol Obstet</source>
            <year>1974</year>
            <month>Jan</month>
            <volume>138</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <page-range>65-8</page-range>
            <pub-id pub-id-type="pmid">4809004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r206">
          <label>206</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spiro</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Huvos</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Strong</surname>
                <given-names>EW</given-names>
              </name>
            </person-group>
            <article-title>Cancer of the parotid gland. A clinicopathologic study of 288 primary cases.</article-title>
            <source>Am J Surg</source>
            <year>1975</year>
            <month>Oct</month>
            <volume>130</volume>
            <issue>4</issue>
            <fpage>452</fpage>
            <page-range>452-9</page-range>
            <pub-id pub-id-type="pmid">170839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r207">
          <label>207</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tusty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Divi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Megwalu</surname>
                <given-names>UC</given-names>
              </name>
            </person-group>
            <article-title>Significance of Nodal Metastasis in Parotid Gland Acinar Cell Carcinoma.</article-title>
            <source>Laryngoscope</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>131</volume>
            <issue>4</issue>
            <fpage>E1125</fpage>
            <page-range>E1125-E1129</page-range>
            <pub-id pub-id-type="pmid">32770798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r208">
          <label>208</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Acinar cell carcinoma: a report of 19 cases with a brief review of the literature.</article-title>
            <source>World J Surg Oncol</source>
            <year>2016</year>
            <month>Jun</month>
            <day>28</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>172</fpage>
            <pub-id pub-id-type="pmid">27352960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r209">
          <label>209</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hickman</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Cawson</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Duffy</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>The prognosis of specific types of salivary gland tumors.</article-title>
            <source>Cancer</source>
            <year>1984</year>
            <month>Oct</month>
            <day>15</day>
            <volume>54</volume>
            <issue>8</issue>
            <fpage>1620</fpage>
            <page-range>1620-4</page-range>
            <pub-id pub-id-type="pmid">6089994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r210">
          <label>210</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bucci</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Quivey</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Eisele</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2007</year>
            <month>Jan</month>
            <day>01</day>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>138</fpage>
            <page-range>138-43</page-range>
            <pub-id pub-id-type="pmid">17049183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r211">
          <label>211</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olsen</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Carcinoma ex pleomorphic adenoma: a clinicopathologic review.</article-title>
            <source>Head Neck</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>23</volume>
            <issue>9</issue>
            <fpage>705</fpage>
            <page-range>705-12</page-range>
            <pub-id pub-id-type="pmid">11505478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r212">
          <label>212</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tortoledo</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Luna</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Batsakis</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes.</article-title>
            <source>Arch Otolaryngol</source>
            <year>1984</year>
            <month>Mar</month>
            <volume>110</volume>
            <issue>3</issue>
            <fpage>172</fpage>
            <page-range>172-6</page-range>
            <pub-id pub-id-type="pmid">6322732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r213">
          <label>213</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stivaros</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Bounds</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Polymorphous low-grade adenocarcinoma--a rare and aggressive entity in adolescence.</article-title>
            <source>Br J Oral Maxillofac Surg</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>195</fpage>
            <page-range>195-9</page-range>
            <pub-id pub-id-type="pmid">15121262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r214">
          <label>214</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castle</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Frommelt</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wenig</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Kessler</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases.</article-title>
            <source>Cancer</source>
            <year>1999</year>
            <month>Jul</month>
            <day>15</day>
            <volume>86</volume>
            <issue>2</issue>
            <fpage>207</fpage>
            <page-range>207-19</page-range>
            <pub-id pub-id-type="pmid">10421256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r215">
          <label>215</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evans</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Luna</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Polymorphous low-grade adenocarcinoma: a study of 40 cases with long-term follow up and an evaluation of the importance of papillary areas.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>10</issue>
            <fpage>1319</fpage>
            <page-range>1319-28</page-range>
            <pub-id pub-id-type="pmid">11023093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r216">
          <label>216</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnes</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Krause</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Contis</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scalamogna</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Salivary duct carcinoma. Part I. A clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature.</article-title>
            <source>Oral Surg Oral Med Oral Pathol</source>
            <year>1994</year>
            <month>Jul</month>
            <volume>78</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-73</page-range>
            <pub-id pub-id-type="pmid">8078666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r217">
          <label>217</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guzzo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Palma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grandi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Molinari</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Salivary duct carcinoma: clinical characteristics and treatment strategies.</article-title>
            <source>Head Neck</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>126</fpage>
            <page-range>126-33</page-range>
            <pub-id pub-id-type="pmid">9059870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r218">
          <label>218</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>WI</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Keum</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>CO</given-names>
              </name>
            </person-group>
            <article-title>Primary squamous cell carcinoma of the parotid gland.</article-title>
            <source>Am J Otolaryngol</source>
            <year>2001</year>
            <season>Nov-Dec</season>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>400</fpage>
            <page-range>400-6</page-range>
            <pub-id pub-id-type="pmid">11713725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r219">
          <label>219</label>
          <element-citation publication-type="journal">
            <collab>International Non-Hodgkin's Lymphoma Prognostic Factors Project</collab>
            <article-title>A predictive model for aggressive non-Hodgkin's lymphoma.</article-title>
            <source>N Engl J Med</source>
            <year>1993</year>
            <month>Sep</month>
            <day>30</day>
            <volume>329</volume>
            <issue>14</issue>
            <fpage>987</fpage>
            <page-range>987-94</page-range>
            <pub-id pub-id-type="pmid">8141877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r220">
          <label>220</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guntinas-Lichius</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Klussmann</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Schroeder</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Quante</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jungehuelsing</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stennert</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Primary parotid malignoma surgery in patients with normal preoperative facial nerve function: outcome and long-term postoperative facial nerve function.</article-title>
            <source>Laryngoscope</source>
            <year>2004</year>
            <month>May</month>
            <volume>114</volume>
            <issue>5</issue>
            <fpage>949</fpage>
            <page-range>949-56</page-range>
            <pub-id pub-id-type="pmid">15126763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r221">
          <label>221</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisele</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Orloff</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Electrophysiologic facial nerve monitoring during parotidectomy.</article-title>
            <source>Head Neck</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>399</fpage>
            <page-range>399-405</page-range>
            <pub-id pub-id-type="pmid">19672866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r222">
          <label>222</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanabria</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kowalski</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Hartl</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Bradford</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>de Bree</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rinaldo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferlito</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sternocleidomastoid muscle flap in preventing Frey's syndrome after parotidectomy: a systematic review.</article-title>
            <source>Head Neck</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>589</fpage>
            <page-range>589-98</page-range>
            <pub-id pub-id-type="pmid">21472880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r223">
          <label>223</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Curry</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Heffelfinger</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Keane</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Pribitkin</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Superficial musculoaponeurotic system elevation and fat graft reconstruction after superficial parotidectomy.</article-title>
            <source>Laryngoscope</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>118</volume>
            <issue>2</issue>
            <fpage>210</fpage>
            <page-range>210-5</page-range>
            <pub-id pub-id-type="pmid">18030169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r224">
          <label>224</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Filho</surname>
                <given-names>WQ</given-names>
              </name>
              <name>
                <surname>Dedivitis</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Rapoport</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guimar&#x000e3;es</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Sternocleidomastoid muscle flap preventing Frey syndrome following parotidectomy.</article-title>
            <source>World J Surg</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>361</fpage>
            <page-range>361-4</page-range>
            <pub-id pub-id-type="pmid">15022023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r225">
          <label>225</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Bree</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van der Waal</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Leemans</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Management of Frey syndrome.</article-title>
            <source>Head Neck</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>29</volume>
            <issue>8</issue>
            <fpage>773</fpage>
            <page-range>773-8</page-range>
            <pub-id pub-id-type="pmid">17230557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r226">
          <label>226</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kolokythas</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Long-term surgical complications in the oral cancer patient: a comprehensive review. Part I.</article-title>
            <source>J Oral Maxillofac Res</source>
            <year>2010</year>
            <volume>1</volume>
            <issue>3</issue>
            <fpage>e1</fpage>
            <pub-id pub-id-type="pmid">24421971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r227">
          <label>227</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Ord</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Complications in the treatment of head and neck cancer.</article-title>
            <source>Oral Maxillofac Surg Clin North Am</source>
            <year>2003</year>
            <month>May</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-27</page-range>
            <pub-id pub-id-type="pmid">18088676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r228">
          <label>228</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schauber</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Fontenelle</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Hanson</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Cranial/cervical nerve dysfunction after carotid endarterectomy.</article-title>
            <source>J Vasc Surg</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>481</fpage>
            <page-range>481-7</page-range>
            <pub-id pub-id-type="pmid">9081129</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r229">
          <label>229</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raaijmakers</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Engelen</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature.</article-title>
            <source>Radiother Oncol</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">12413668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r230">
          <label>230</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dawson</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Orr</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Long-term results of local excision and radiotherapy in pleomorphic adenoma of the parotid.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>1985</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>451</fpage>
            <page-range>451-5</page-range>
            <pub-id pub-id-type="pmid">2982770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r231">
          <label>231</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Slevin</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Gleave</surname>
                <given-names>EN</given-names>
              </name>
            </person-group>
            <article-title>Radiotherapy for pleomorphic adenoma of the parotid gland.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>1992</year>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>925</fpage>
            <page-range>925-8</page-range>
            <pub-id pub-id-type="pmid">1313407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r232">
          <label>232</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leonetti</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Marzo</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Zender</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Melian</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Temporal bone osteoradionecrosis after surgery and radiotherapy for malignant parotid tumors.</article-title>
            <source>Otol Neurotol</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>656</fpage>
            <page-range>656-9</page-range>
            <pub-id pub-id-type="pmid">20964249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r233">
          <label>233</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pauloski</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Logemann</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rademaker</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>McConnel</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Heiser</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Cardinale</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shedd</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lewin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Graner</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Speech and swallowing function after anterior tongue and floor of mouth resection with distal flap reconstruction.</article-title>
            <source>J Speech Hear Res</source>
            <year>1993</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>267</fpage>
            <page-range>267-76</page-range>
            <pub-id pub-id-type="pmid">8487519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r234">
          <label>234</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rentschler</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>The effects of glossectomy on intelligibility of speech and oral perceptual discrimination.</article-title>
            <source>J Oral Surg</source>
            <year>1980</year>
            <month>May</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>348</fpage>
            <page-range>348-54</page-range>
            <pub-id pub-id-type="pmid">6928933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31299.r235">
          <label>235</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brands</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Brennan</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Verbeek</surname>
                <given-names>ALM</given-names>
              </name>
              <name>
                <surname>Merkx</surname>
                <given-names>MAW</given-names>
              </name>
              <name>
                <surname>Geurts</surname>
                <given-names>SME</given-names>
              </name>
            </person-group>
            <article-title>Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature.</article-title>
            <source>Eur J Surg Oncol</source>
            <year>2018</year>
            <month>May</month>
            <volume>44</volume>
            <issue>5</issue>
            <fpage>559</fpage>
            <page-range>559-565</page-range>
            <pub-id pub-id-type="pmid">29433990</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
